COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 NO. 95, 1989 COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 NO. 95, 1989 - TABLE OF PROVISIONS 1. Short title 2. Commencement 3. Principal Act 4. Interpretation 5. Directions by Minister 6. Confidentiality 7. Principal Act 8. Interpretation 9. Certification of in-patient as needing acute care 10. 11. 12. Multiple pathology services 13. Manner of making determinations under sections 4BA and 4BB 14. Increased fee in complex cases 15. Appeal from decision on increased fee 16. Repeal of provisions establishing the Pathology Services Advisory Committee 17. Prohibition of certain medical insurance 18. Repeal of Schedule 1A and substitution of new Schedule 19. Principal Act 20. Interpretation 21. 22. 23. Interim decisions on applications under subsection 40AD (1B) 24. Application by proprietor of home for patient classification 25. Review by Secretary of classification 26. 27. 28. Application by organisation for registration as health benefits organisation or to carry on health insurance business 29. Giving of information by applicant organisations 30. Application to be referred to Committee 31. Report of the Committee 32. Matters to be taken into account by Committee and by Ministers 33. Registration and permission to carry on business as registered health benefits organisation 34. Registered organisation not to carry on other business etc. 35. Minimum reserves 36. Exemption from maximum reserve conditions 37. Reinsurance Account in health benefits fund 38. Health Benefits Reinsurance Trust Fund 39. Repeal 40. Conduct of health benefits funds 41. Repeal of sections 76, 76A and 77 42. Changes of rules etc. by registered organisations 43. Cancellation of registration of organisation 44. Offences 45. 46. Investigation of organisation by inspector 47. Application for judicial management or winding up of a fund 48. Merger of funds 49. Application for review by Tribunal 50. Officers to observe secrecy 51. 52. Regulations 53. Schedule 54. Saving 55. Principal Act 56. Interpretation 57. Approval in principle of nursing home etc. 58. Approval of nursing home 59. Application of National Health Act 60. Approval of additional services 61. Common form of nursing home agreement 62. Certain notices to be subject to disallowance 63. Principal Act 64. Inquiries and determinations by Tribunal 65. Principal Act 66. Interpretation 67. Special nurse education transfer grants 68. SCHEDULE COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - LONG TITLE An Act to amend laws relating to community services and health, and for related purposes COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 1 Short title (Assented to 28 June 1989) 1. This Act may be cited as the Community Services and Health Legislation Amendment Act 1989. (Minister's second reading speech made in- House of Representatives on 10 May 1989 Senate on 26 May 1989) COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 2 Commencement 2. (1) Subject to subsections (2), (3), (4), (5), (6), (7), (8), (9) and (10), this Act commences on the day on which it receives the Royal Assent. (2) Part 7 shall be taken to have commenced on 1 January 1989. (3) Section 23 shall be taken to have commenced on 15 March 1989. (4) Paragraphs 37 (a) to (k) (inclusive) and (s) commence, or shall be taken to have commenced, on 1 June 1989. (5) Part 5 commences on 1 July 1989. (6) Sections 11, 12, 13, 14, 15, 16 and 18 and the Schedule commence on 1 August 1989. (7) Subject to subsection (8), subsection 20 (2), sections 21, 22, 28, 29, 30, 31, 32, 33, 43 and 44, subsection 53 (2) and section 54 commence on a day or days to be fixed by Proclamation. (8) If a provision referred to in subsection (7) does not commence within the period of 6 months beginning on the day on which this Act receives the Royal Assent, it commences at the end of that period. (9) Subject to subsection (10), section 10 commences on a day to be fixed by Proclamation. (10) The day fixed by Proclamation for the commencement of section 10 shall be a day not earlier than the day immediately after the day on which the Senate, by resolution, having concluded debate on the report of the Senate Select Committee on Health Legislation and Health Insurance on section 10 of this Act, approves proposed new sections 3F, 3G and 3H of the Health Insurance Act 1973 as contained in section 10 of this Act. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 3 Principal Act 3. In this Part, "Principal Act" means the Australian Institute of Health Act 1987*1*. *1* No. 41, 1987, as amended. For previous amendments, see No. 79, 1988. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 4 Interpretation 4. Section 3 of the Principal Act is amended by inserting the following definition in subsection (1): " 'State Health Minister' means: (a) the Minister of the Crown for a State; (b) the Minister of the Australian Capital Territory; or (c) the Minister of the Northern Territory; who is responsible, or principally responsible, for the administration of matters relating to health in the State, the Australian Capital Territory or the Northern Territory, as the case may be;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 5 Directions by Minister 5. Section 7 of the Principal Act is amended by inserting in subsection (1) "and each of the State Health Ministers" after "with the Chairperson". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 6 Confidentiality 6. Section 29 is amended: (a) by omitting paragraphs (2) (b) and (c) and substituting the following paragraphs: "(b) a person from divulging or communicating information, or producing a document, to a person specified in writing by the person (in this subsection called the 'information provider') who divulged or communicated the information, or produced the document, directly to the Institute; (c) a person from divulging or communicating information, or producing a document, to a person specified in writing by the Australian Institute of Health Ethics Committee if to do so is not contrary to the written terms and conditions (if any) upon which the information provider divulged or communicated the information, or produced the document, directly to the Institute; or (d) the publication of conclusions based on statistics derived from, or of particulars of procedures used in, the work of the Institute, if: (i) to do so is not contrary to the written terms and conditions (if any) upon which an information provider divulged or communicated information relevant to the publication, or produced a document relevant to the publication, directly to the Institute; and (ii) the publication does not identify the information subject."; (b) by omitting from subsection (3) "or (b)" and substituting ", (b) or (c),"; (c) by omitting from paragraph (4) (b) all words from and including "and" and substituting the following words and subparagraphs: "and also includes: (i) in the case of an information provider-a body politic; or (ii) in the case of an information subject-a deceased person.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 7 Principal Act 7. In this Part, "Principal Act" means the Health Insurance Act 1973*2*. *2* No. 42, 1974, as amended. For previous amendments, see No. 58, 1975; Nos. 59, 91, 101, 109 and 157, 1976; No. 75, 1977; Nos. 36, 89 and 133, 1978; Nos. 53 and 123, 1979; No. 132, 1980; Nos. 118 and 176, 1981; Nos. 49, 80 and 112, 1982; Nos. 54 and 139, 1983; Nos. 15, 46, 63, 120, 135 and 165, 1984; Nos. 24, 65, 70, 95 and 167, 1985; Nos. 28, 75 and 94, 1986; Nos. 44, 131, 132 and 141, 1987; and Nos. 85, 87, 99 and 155, 1988. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 8 Interpretation 8. Section 3 of the Principal Act is amended by inserting in subsection (1) the following definition: " 'vocationally registered general practitioner' means a medical practitioner registered under section 3F;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 9 Certification of in-patient as needing acute care 9. (1) Section 3B of the Principal Act is amended: (a) by omitting from paragraph (5) (b) "an application in writing is made to him" and substituting "receiving from the Private Health Insurance Administration Council a copy of an application in writing made to it"; (b) by omitting subsection (8) and substituting the following subsection: "(8) The Secretary may establish a Committee or Committees to be known as the Acute Care Advisory Committee or the Acute Care Advisory Committees.". (2) Notwithstanding the amendments made by this section, an Acute Care Advisory Committee reviewing a certificate on the commencement of this section shall continue the review as if the amendment had not been made. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 10 10. After section 3E of the Principal Act the following sections are inserted: Vocationally registered general practitioners "3F. (1) The purpose of this section is to provide for the registration of certain medical practitioners as vocationally registered general practitioners. Note: Some items in the general medical services table apply only to services rendered by medical practitioners who are registered under this section. "(2) The Commission is to establish and maintain a Vocational Register of General Practitioners. "(3) The Register may be maintained in any form, including the form of a computer record. "(4) A medical practitioner may apply to the Commission for registration under this section. "(5) The application must be made in a manner approved by the Minister. "(6) If: (a) the General Manager of the Commission is satisfied that the Royal Australian College of General Practitioners has certified that the applicant's medical practice is predominantly general practice and that the applicant has training and experience in general practice that make it appropriate for the applicant to be registered under this section; or (b) the applicant is, in accordance with the regulations, eligible for registration under this section; the General Manager shall, within 14 days after receiving the application, enter the applicant's name in the Register. "(7) The General Manager of the Commission shall give the applicant written notice of the day on which the applicant's name is to be entered in the Register. "(8) The Commission may give the Royal Australian College of General Practitioners information about: (a) the current state of the Register; (b) additions to the Register; and (c) deletions from the Register. "(9) The General Manager of the Commission or an authorised officer may make available to members of the public, on request, the names of medical practitioners who are registered under this section and the addresses at which they practise. "(10) In the section: 'authorised officer' means a Commission staff member authorised by the General Manager of the Commission as an authorised officer for the purposes of this section; 'Commission staff member' means a member of the staff of the Commission referred to in subsection 28 (1) of the Health Insurance Commission Act 1973. Removal from Register "3G. (1) The General Manager of the Commission shall remove a medical practitioner's name from the Vocational Register of General Practitioners if: (a) the medical practitioner requests the General Manager to do so; (b) the Royal Australian College of General Practitioners gives the General Manager written notice that: (i) the College is no longer satisfied that the medical practitioner's medical practice is predominantly general practice; (ii) the College is no longer satisfied that it is appropriate for the medical practitioner to be registered under section 3F; or (iii) the medical practitioner has failed to meet the College's minimum requirements for participation in continuing medical education and quality assurance programs; or (c) removal is required by regulations made for the purposes of this paragraph. "(2) Where the General Manager decides that a medical practitioner's name should be removed from the Register, the General Manager shall give the medical practitioner written notice of the decision. "(3) The decision shall be made in writing and shall specify the day on which the medical practitioner's name is to be removed from the Register. "(4) The day specified under subsection (3) shall be not less than 14 days after the day on which the decision is made. Minister's powers to make determinations "3H. (1) The Minister may, by notice published in the Gazette, determine that a reference in section 3F or 3G to the Royal Australian College of General Practitioners is to be taken to be a reference to the body specified in the determination. "(2) If a determination is made under subsection (1), section 3F or 3G applies as if the reference to the College were a reference to the body specified in the determination.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 11 11. Section 4A of the Principal Act is repealed and the following section is substituted: Variations and alterations of pathology services table "4A. (1) The regulations may provide that this Act shall have effect as if the pathology services table were varied: (a) by omitting an item or rule of interpretation from the table; (b) by inserting an item or rule of interpretation in the table; or (c) by substituting another amount for an amount set out in the table. "(2) The regulations may prescribe a table of pathology services in accordance with the form of table set out in Schedule 1A. "(3) On the commencement of a regulation prescribing a table of pathology services: (a) the table so prescribed has effect as if it were set out in Schedule 1A in the place of the table (in this subsection referred to as 'the superseded table') in that Schedule; and (b) the superseded table or, if another table has effect, by virtue of this section, in the place of the superseded table, that other table ceases to have effect. "(4) The regulations may amend a table that has effect by virtue of paragraph (3) (a) and, on the commencement of the amendment, the table as so amended has effect in the place of the first-mentioned table. "(5) In this section, a reference to a table of pathology services shall be read as including a reference to rules for the interpretation of that table. "(6) Regulations under this section shall, unless sooner repealed, cease to be in force on the day next following the 15th sitting day of the House of Representatives after the expiration of a period of 12 months commencing on the day on which the regulations are notified in the Gazette, and shall be deemed to have been repealed on the first-mentioned day.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 12 Multiple pathology services 12. Section 4B of the Principal Act is amended by omitting from subsection (2) "determination" and substituting "regulation". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 13 Manner of making determinations under sections 4BA and 4BB 13. Section 4BC of the Principal Act is amended by omitting from subsection (1) "4A,". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 14 Increased fee in complex cases 14. Section 11 of the Principal Act is amended: (a) by omitting from subsections (2) "the professional service referred to in the claim is a service other than a pathology service and"; (b) by omitting subsection (2A); (c) by omitting from subsection (3) "or (2A) (b)". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 15 Appeal from decision on increased fee 15. Section 12 of the Principal Act is amended: (a) by omitting from subsections (2), (3), (4) and (6) "relevant committee" (wherever occurring) and substituting "Medicare Benefits Advisory Committee"; (b) by omitting subsection (8). COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 16 Repeal of provisions establishing the Pathology Services Advisory Committee 16. Division 2A of Part V of the Principal Act is repealed. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 17 Prohibition of certain medical insurance 17. Section 126 of the Principal Act is amended: (a) by omitting from subsection (1) "indemnify the other person in respect of loss arising out" and substituting "make a payment in the event"; (b) by omitting from subsection (2) "indemnify a person in respect of loss arising out" and substituting "make a payment in the event". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 18 Repeal of Schedule 1A and substitution of new Schedule 18. Schedule 1A to the Principal Act is repealed and the Schedule set out in the Schedule to this Act is substituted. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 19 Principal Act 19. In this Part, "Principal Act" means the National Health Act 1953*3*. *3* No. 95, 1953, as amended. For previous amendments, see No. 68, 1955; Nos. 55 and 95, 1956; No. 92, 1957; No. 68, 1958; No. 72, 1959; No. 16, 1961; No. 82, 1962; No. 77, 1963; No. 37, 1964; Nos. 100 and 146, 1965; No. 44, 1966; Nos. 14 and 100, 1967; No. 100, 1968; No. 102, 1969; No. 41, 1970; No. 85, 1971; No. 114, 1972; Nos. 49 and 202, 1973; No. 37, 1974; Nos. 1, 13 and 93, 1975; Nos. 1, 60, 91, 99, 108, 157 and 177, 1976; Nos. 98 and 100, 1977; Nos. 36, 88, 132 and 189, 1978; Nos. 54, 91 and 122, 1979; Nos. 117 and 131, 1980; Nos. 40, 74, 92, 118, 163 and 176, 1981; Nos. 49, 80 and 112, 1982; Nos. 35, 54 and 139, 1983; Nos. 46, 63, 72, 120, 135 and 165, 1984; Nos. 24, 53, 65, 70, 95, 127 and 167, 1985; Nos. 28, 75, 94 and 115, 1986; Nos. 22, 44, 72, 118, 131 and 132, 1987; and Nos. 79, 87, 99 and 155, 1988. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 20 Interpretation 20. (1) Section 4 of the Principal Act is amended by inserting in subsection (1) the following definitions: " 'Council' means the Private Health Insurance Administration Council established by section 82B; 'Council's rules' means rules made by the Council in the performance of its functions under paragraph 82G (r);". (2) Section 4 of the Principal Act is amended: (a) by omitting paragraph (a) of the definition of "basic private table" or "basic table" in subsection (1) (in this section called the "relevant definition") and substituting the following paragraph: "(a) in respect of hospital treatment provided to patients (other than nursing-home type patients) in a hospital in the State or Territory to which the table relates for the purpose of permitting the provision to them at the hospital of: (i) type-A professional attention; or (ii) professional attention that, under subsection 4C (1), is taken to be professional attention to which this paragraph applies; where the hospital treatment has been provided for a period that includes part of an overnight stay-benefits equal to the amount of the standard hospital fees in relation to that State or Territory;"; (b) by omitting from paragraph (b) of the relevant definition "persons as in-patients" and "that patient is an in-patient" and substituting "nursing-home type patients" and "hospital treatment is provided to that patient" respectively; (c) by omitting from paragraph (b) of the relevant definition ", being nursing-home type patients"; (d) by omitting from paragraph (c) of the relevant definition "persons as in-patients" and "that patient was an in-patient" and substituting "nursing-home type patients" and "hospital treatment is provided to that patient" respectively; (e) by omitting from paragraph (c) of the relevant definition ", being nursing-home type patients"; (f) by omitting from paragraph (d) of the relevant definition "persons as in-patients" and substituting "patients"; (g) by omitting from paragraph (da) of the relevant definition "the person is an in-patient of" and substituting "hospital treatment is provided to the person in"; (h) by omitting paragraphs (db) and (dc) of the relevant definition and substituting the following paragraphs: "(db) in respect of hospital treatment provided to a patient in a hospital for the purpose of permitting the provision to the patient at the hospital of: (i) type-A professional attention; (ii) type-B professional attention; or (iii) professional attention that is, under subsection 4C (2), to be taken to be professional attention to which this paragraph applies; where the hospital treatment has been provided for a period that does not include part of an overnight stay-a benefit equal to the amount that, under the determination made by the Minister under paragraph 4D (1) (a), is payable in respect of that hospital treatment; (dc) in respect of hospital treatment provided to a person in a day hospital facility for the purpose of permitting the provision to the person at the day hospital facility of professional attention other than type-C professional attention-a benefit equal to the amount that, under the determination made by the Minister under paragraph 4D (1) (b), is payable in respect of that hospital treatment;"; (j) by omitting from paragraph (dd) of the relevant definition "person who is an in-patient" and substituting "patient while hospital treatment is provided to the patient"; (k) by inserting in subsection (1) the following definitions: " 'patient', in relation to a hospital, does not include: (a) a member of the staff of the hospital who is receiving treatment in his or her own quarters; or (b) except as provided by subsection 3 (2) of the Health Insurance Act 1973, a newly-born child whose mother also occupies a bed in the hospital; 'type-A professional attention' means professional attention, other than professional attention to which a determination under paragraph 4B (a) relates, the provision of which to a patient normally requires that the patient be given hospital treatment in a hospital; 'type-B professional attention' means professional attention to which a determination under paragraph 4B (a) relates; 'type-C professional attention' means professional attention to which a determination under paragraph 4B (b) relates;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 21 21. After section 4A of the Principal Act the following sections are inserted: Determinations-professional attention "4B. The Minister may make the following determinations in writing: (a) a determination that the provision of professional attention of a kind specified in the determination normally requires hospital treatment in a hospital but does not require such hospital treatment for a period that includes part of an overnight stay; (b) a determination that the provision of professional attention of a kind specified in the determination does not normally require hospital treatment. Certificates in respect of professional attention "4C. (1) Where: (a) hospital treatment is provided, for a period that includes part of an overnight stay, to a patient in a hospital for the purpose of permitting the provision to the patient at the hospital of professional attention other than type-A professional attention; and (b) the practitioner providing the professional attention certifies in writing that: (i) because of the medical condition of the patient specified in the certificate; or (ii) because of the special circumstances specified in the certificate; it would be contrary to accepted medical practice to provide the professional attention to the patient unless the patient were given hospital treatment in the hospital for a period that includes part of an overnight stay; the professional attention shall be taken to be professional attention to which paragraph (a) of the definition of 'basic private table' or 'basic table' in subsection 4 (1) (in this section called the 'relevant definition') applies. "(2) Where: (a) hospital treatment is provided, for a period that does not include part of an overnight stay, to a patient in a hospital for the purpose of permitting the provision to the patient at the hospital of professional attention other than type-A professional attention or type-B professional attention; and (b) the practitioner providing the professional attention certifies in writing that: (i) because of the medical condition of the patient specified in the certificate; or (ii) because of the special circumstances specified in the certificate; it would be contrary to accepted medical practice to provide the professional attention to the patient unless the patient were given hospital treatment in the hospital for a period that does not include part of an overnight stay; the professional attention shall be taken to be professional attention to which paragraph (db) of the relevant definition applies. Determination-amount of benefit "4D. (1) The Minister may, in relation to a State or Territory: (a) determine, for the purposes of paragraph (db) of the definition of 'basic private table' or 'basic table' in subsection 4 (1) (in this section called the 'relevant definition'), the amount payable in respect of hospital treatment provided in hospitals in the State or Territory; and (b) determine, for the purposes of paragraph (dc) of the relevant definition, the amount payable in respect of hospital treatment provided in day hospital facilities in the State or Territory. "(2) In making a determination under subsection (1), the Minister may determine: (a) different amounts in respect of hospital treatment relating to the provision of different classes of professional attention; and (b) in the case of a determination for the purposes of paragraph (db) of the relevant definition-different amounts in respect of hospital treatment provided in different classes of hospital.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 22 22. Section 5 of the Principal Act is repealed and the following section is substituted: Certain determinations to be disallowable instruments "5. (1) In this section: 'determination' means: (a) a determination for the purposes of paragraph (dd) of the definition of 'basic private table' or 'basic table' in subsection 4 (1); (b) a determination under section 4B; or (c) a determination under subsection 4D (1). "(2) A determination is a disallowable instrument for the purposes of section 46A of the Acts Interpretation Act 1901.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 23 Interim decisions on applications under subsection 40AD (1B) 23. Section 40ADA of the Principal Act is amended by omitting from subsection (6) "(2)" and substituting "(1)". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 24 Application by proprietor of home for patient classification 24. Section 40AFD of the Principal Act is amended: (a) by omitting from subsection (1) "When" and substituting "Subject to section 40AFJ, when"; (b) by omitting from subsection (2) "The" and substituting "Subject to section 40AFJ, the". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 25 Review by Secretary of classification 25. Section 40AFE of the Principal Act is amended by omitting from subsection (5) all words to and including "written" and substituting the following: "The Secretary shall, as soon as practicable, give in writing: (a) to the proprietor of the nursing home; and (b) if another person or body applied for the classification of the nursing home patient under section 40AFD-to that other person or body;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 26 26. After section 40AFF of the Principal Act the following sections are inserted: Determination by Secretary where classifications found to be inaccurate "40AFG. (1) In subsection (2): 'review' means: (a) a review under section 40AFE; or (b) where a review under that section has been confirmed by the Minister under section 40AFF, the review as so confirmed by the Minister. "(2) Where reviews of classifications of patients in a nursing home have in a substantial number of cases resulted in: (a) those classifications being revoked on the ground that they were based on inaccurate information given by the proprietor of the nursing home; and (b) lower classifications being substituted for them; the Secretary may: (c) determine in writing that section 40AFD does not apply in relation to the proprietor; and (d) nominate in the determination the person or body who is to make applications for the purposes of that section in the place of the proprietor. "(3) Unless it is set aside by the Minister under subsection 40AFH (2), a determination remains in force for the period specified in the determination. "(4) The Secretary shall, as soon as practicable, give in writing to the proprietor of the nursing home notice of: (a) the determination; (b) the reasons for the determination; and (c) the rights of the proprietor under section 40AFH. Review of determination "40AFH. (1) A proprietor of a nursing home dissatisfied with a determination under subsection 40AFG (2) may, within 28 days after the day on which notice of the determination was given to the proprietor, request in writing the Minister to review the determination. "(2) The Minister shall review the determination and may: (a) confirm it; (b) set it aside; or (c) set it aside and substitute any determination that the Minister thinks appropriate. "(3) A determination by the Minister under paragraph (2) (c) remains in force for the period specified in the determination. "(4) The Minister shall, as soon as practicable, give in writing to the proprietor of the nursing home: (a) notice of his or her decision under subsection (2); and (b) if the Minister has confirmed the determination of the Secretary or substituted another determination for it-the reasons for the decision. Effect of determination on applications for patient classification "40AFJ. Where there is in force a determination under subsection 40AFG (2) or 40AFH (2) in relation to the proprietor of a nursing home, the following provisions apply: (a) the proprietor may not apply to the Secretary under section 40AFD for the classification of patients in the nursing home; (b) any application under that section in respect of a patient in the nursing home shall be made by the person or body nominated for that purpose in the determination; (c) the Secretary shall give to the proprietor notice of any classification in respect of a nursing home patient granted under an application made in accordance with paragraph (b); (d) where an application under subsection 40AFD (2) for the classification of a nursing home patient is made in accordance with paragraph (b): (i) subsections 40AFD (7) to (10) (inclusive) do not apply in relation to the application; and (ii) the classification granted on the application takes effect, or is to be regarded as having taken effect, at the expiration of the previous classification of the patient. Proprietor to be given notice of classification of classified patient admitted to nursing home "40AFK. Where a person in respect of whom a classification under section 40AFA is in force is admitted to an approved nursing home, the Secretary shall, on request, give to the proprietor of the nursing home written notice of the classification and of the day on which the classification expires.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 27 27. After section 67 of the Principal Act the following section is inserted: Injunctions for contravention of section 67 "67A. (1) Where, on the application of the Minister, the Council or any other person, the Federal Court of Australia is satisfied that a person has engaged, or is proposing to engage, in conduct that constitutes or would constitute a contravention of subsection 67 (1), the Court may grant an injunction in such terms as the Court determines to be appropriate. "(2) Where in the opinion of the Court it is desirable to do so, the Court may grant an interim injunction pending determination of an application under subsection (1). "(3) The Court may rescind or vary an injunction granted under subsection (1) or (2). "(4) The power of the Court to grant an injunction restraining a person from engaging in conduct may be exercised: (a) whether or not it appears to the Court that the person intends to engage again, or to continue to engage, in conduct of that kind; and (b) whether or not the person has previously engaged in conduct of that kind. "(5) The power of the Court to grant an injunction requiring a person to do an act or thing may be exercised: (a) whether or not it appears to the Court that the person intends to refuse or fail again, or to continue to refuse or fail, to do that act or thing; and (b) whether or not the person has previously refused or failed to do that act or thing.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 28 Application by organisation for registration as health benefits organisation or to carry on health insurance business 28. (1) Section 68 of the Principal Act is amended: (a) by omitting subsection (1) and substituting the following subsections: "(1) In this section: 'State', except in subsections (2), (2A) and (3), includes the Northern Territory. "(1A) An organisation may apply for registration as a registered health benefits organisation. "(1B) An application shall specify the State or States in which the organisation proposes to carry on business as a registered health benefits organisation. "(1C) It is a condition of the registration of a registered health benefits organisation that it only carries on business as a registered health benefits organisation in the State or States: (a) specified in its application for registration; (b) specified in a successful application by it under subsection (1D); or (c) in which it has a fund transferred to it under paragraph 82ZP (1) (b). "(1D) A registered health benefits organisation may apply to carry on business as a registered health benefits organisation in a specified State, or specified States, not specified in its application for registration."; (b) by omitting from subsection (2) "be registered as a registered health benefits organisation in respect of a State" and substituting "carry on business as a registered health benefits organisation in a State"; (c) by omitting from subparagraph (2) (c) (v) "Administrators" and substituting "Council"; (d) by omitting from paragraph (2A) (c) "in respect of" and substituting "in an application specifying, or applies to carry on business as a registered health benefits organisation in,"; (e) by omitting from subsection (3) "be registered as a registered health benefits organisation in respect of" and substituting "carry on business as a registered health benefits organisation in"; (f) by omitting subparagraph (3) (a) (i) and substituting the following subparagraph: "(i) the Northern Territory is to be treated as part of another State in which the organisation, carries on, or proposes to carry on, business as a registered health benefits organisation;"; (g) by omitting from subsection (4) "be registered as a registered health benefits organisation in respect of any State or in respect of the Northern Territory" and substituting "carry on business as a registered health benefits organisation in any State"; (h) by omitting from subparagraph (4) (c) (iv) "Administrators" and substituting "Council". (2) Where, immediately before the commencement of this section, an organisation was a registered health benefits organisation: (a) the organisation shall be taken to be registered under section 68 of the Principal Act as amended by this section; and (b) for the purposes of subsection 68 (1C) of that section, every State and Territory in respect of which the organisation was registered as a registered health benefits organisation immediately before that commencement shall be taken to have been specified in the application for registration under that section. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 29 Giving of information by applicant organisations 29. Section 69 of the Principal Act is amended by inserting ", or for permission to carry on business as a registered health benefits organisation" after "registration" (wherever occurring). COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 30 Application to be referred to Committee 30. Section 71 of the Principal Act is amended by inserting "or for permission to carry on business as a registered health benefits organisation" after "registration". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 31 Report of the Committee 31. Section 72 of the Principal Act is amended by inserting ", or permission to carry on business as a registered health benefits organisation, as the case requires," after "organisation". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 32 Matters to be taken into account by Committee and by Ministers 32. Section 72A of the Principal Act is amended: (a) by omitting "in respect of" and substituting "or for permission to carry on business as a registered health benefits organisation in"; (b) by inserting "or to carry on that business in the State or Territory, as the case may be" after "registered"; (c) by inserting in paragraph (a) "or funds" after "fund"; (d) by inserting in paragraphs (b) and (c) "or those funds" after "fund" (wherever occurring); (e) by inserting in paragraph (d) "in respect of that fund or each of those funds-" before "the ratio". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 33 Registration and permission to carry on business as registered health benefits organisation 33. Section 73 of the Principal Act is amended: (a) by inserting in subsection (2AA) "for registration" after "application" (first occurring); (b) by omitting from subsection (2A) "for registration by an organisation" and substituting "by an organisation for registration or to carry on business as a registered health benefits organisation"; (c) by inserting in subsection (2A) "or a relevant fund" after "fund"; (d) by adding at the end the following subsections: "(9) Where the Minister grants an application by a registered organisation to carry on business as a registered health benefits organisation in a State or the Northern Territory, the Minister shall, within one month after the Minister has granted the application publish in the Gazette a notification to that effect setting out: (a) the name of the organisation; and (b) the name of the State or Territory. "(10) Where the Minister refuses an application by a registered organisation to carry on business as a registered health benefits organisation in a State or the Northern Territory, the Minister shall, within one month after so refusing the application publish in the Gazette a notification of the refusal.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 34 Registered organisation not to carry on other business etc. 34. Section 73BAA of the Principal Act is repealed. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 35 Minimum reserves 35. Section 73BAB of the Principal Act is amended: (a) by omitting subsection (1) and substituting the following subsections: "(1) It is a condition of registration of a registered organisation that, where it conducts only one health benefits fund, the value of the assets of that fund shall at all times exceed the sum of: (a) whichever is the higher of: (i) the prescribed minimum amount; or (ii) the amount (if any) by which the sum of the amounts debited to that fund during the last preceding prescribed period of the organisation exceeds the amount of income received during that period from assets of that fund consisting of investments; (b) the liabilities that are required to be met out of that fund; (c) the amount of any subsisting guarantee, not falling within paragraph (b), given by the organisation in relation to a prescribed company; (d) the sum of the amounts of payments by way of calls in respect of shares in a prescribed company, not falling within paragraph (b), that the organisation is, or could become, liable to pay; and (e) any other amount that the Minister, after taking into account the advice of the Council, considers should be a liability for the purposes of this subsection. "(1A) It is a condition of registration of a registered health benefits organisation that, where it conducts 2 or more health benefits funds, the value of the assets of each of those funds shall at all times exceed the sum of: (a) the amount (if any) by which the sum of the amounts debited to that fund during the last preceding prescribed period of the organisation exceeds the amount of income received during that period from assets of that fund consisting of investments; (b) the liabilities that are required to be met out of that fund; (c) so much as the Minister, by instrument in writing, determines of the amount of any subsisting guarantee, not falling within paragraph (b), given by the organisation in relation to a prescribed company; (d) the amount equal to so much as the Minister, by instrument in writing, determines of the sum of the amounts of payments by way of calls in respect of shares in a prescribed company, not falling within paragraph (b), that the organisation is, or could become, liable to pay; and (e) any other amount that the Minister, after taking into account the advice of the Council, considers should be a liability for the purposes of this subsection. "(1B) It is a condition of registration of a registered health benefits organisation that, where it conducts 2 or more health benefits funds, the value of the sum of the assets of all those funds shall at all times exceed the sum of: (a) whichever is the higher of: (i) the prescribed minimum amount; or (ii) the amount (if any) by which the sum of the amounts debited to those funds during the last preceding prescribed period of the organisation exceeds the amount of income received during that period from assets of those funds consisting of investments; (b) the liabilities that are required to be met out of those funds; (c) the amount of any subsisting guarantee, not falling within paragraph (b), given by the organisation in relation to a prescribed company; (d) the sum of the amounts of payments by way of calls in respect of shares in a prescribed company, not falling within paragraph (6), that the organisation is, or could become, liable to pay; and (e) any other amount that the Minister, after taking into account the advice of the Council, considers should be a liability for the purposes of this subsection."; (b) by omitting from paragraph (2) (b) "or" (last occurring); (c) by adding at the end of subsection (2) the following word and paragraph: "; or (d) any property that the Minister, after taking into account the advice of the Council, considers should not be an asset for the purposes of this section."; (d) by inserting in subsection (3) the following definitions: " 'prescribed minimum amount' means $1,000,000 or, if a higher amount is prescribed, that higher amount; 'property' includes an interest, power, right or privilege;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 36 Exemption from maximum reserve conditions 36. (1) Section 73BAC of the Principal Act is amended by omitting subsection (1) and substituting the following subsections: "(1) Upon application in writing made to the Minister by a registered organisation, the Minister, after consulting the Council, may, by notice in writing served on the public officer of the organisation, exempt the organisation from compliance with the conditions referred to in section 73BAB. "(1B) An application by an organisation under subsection (1) shall be accompanied by such evidence, valuations or actuarial certification of the assets and liabilities of the organisation as the Minister considers appropriate.". (2) Where immediately before the amendment of section 73BAB of the Principal Act made by this Act, an exemption of an organisation from compliance with the condition referred to in that section was in force, that exemption shall be taken to be an exemption under subsection 73BAC (1) of the Principal Act as amended by subsection (1). COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 37 Reinsurance Account in health benefits fund 37. Section 73BB of the Principal Act is amended: (a) by omitting from subsection (2) "this section" and substituting "subsections (3), (4) and (8)"; (b) by inserting in subsection (2) "or a supplementary hospital table" after "Schedule)"; (c) by inserting in subsection (2) "for a person who has not, or persons who have not, reached the prescribed age" after "matter" (first occurring); (d) by inserting in paragraph (2) (a) "such" before "person"; (e) by inserting in paragraph (2) (b) "such" before "persons" (first occurring); (f) by omitting from subsection (3) "this section" and substituting "subsection (4)"; (g) by omitting from subsection (4) "section" (first occurring) and substituting "subsection"; (h) by inserting in subsection (4) "or a supplementary hospital table" after "Schedule)"; (j) by omitting from subsection (4) "section" (last occurring) and substituting "subsection"; (k) by inserting after subsection (4) the following subsection: "(5) A registered organisation may debit to the Reinsurance Account maintained by it in a health benefits fund the amounts of any payments of any benefits made out of that fund in accordance with a basic table (whether or not modified by an election of the kind referred to in the condition set out in paragraph (ba) of the Schedule) or a supplementary hospital table to a contributor in respect of the provision of treatment, a service or another matter for a person who has reached the prescribed age."; (m) by omitting subsection (5A); (n) by omitting from paragraph (7) (a) "Minister" and substituting "Council"; (p) by omitting paragraph 7 (c) and substituting the following paragraph: "(c) shall give to the Council, at such times as the Council determines, such information drawn from the records referred to in paragraph (a) as the Council requires."; (q) by omitting subsection (9) and substituting the following subsection: "(9) This section only applies to classes of benefits declared by the Minister, by notice published in the Gazette, to be classes of benefits for the purposes of reinsurance."; (r) by omitting from subsection (11) the definition of "nursing home fund benefit"; (s) by inserting in subsection (11) the following definition: " 'prescribed age' means 65 years or, if another age is prescribed, that other age;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 38 Health Benefits Reinsurance Trust Fund 38. Section 73BC of the Principal Act is amended: (a) by omitting from subsection (1) "and the Commonwealth"; (b) by inserting in that subsection ", and for the Commonwealth to make a payment towards," before "meeting"; (c) by omitting subsection (4); (d) by omitting paragraph (5) (a) and substituting the following paragraph: "(a) such amount as is appropriated by the Parliament in the financial year ending on 30 June 1989 for payment into the Fund;"; (e) by omitting subsections (5B), (5C) and (5D) and substituting the following subsections: "(5B) The Minister shall determine in writing principles relating to the operation of the Fund. "(5C) The principles shall include principles for determining the method of, and the matters to be taken into account in, calculating the amounts to be paid into the Fund by registered health benefits organisations. "(5D) Where the Minister determines or varies the principles, he or she shall as soon as practicable: (a) notify the Council of the principles or variation, as the case may be; and (b) cause a copy of the principles or particulars of the variation, as the case may be, to be published in the Gazette. "(5E) The Council shall exercise its functions and powers in relation to the Fund in accordance with the principles."; (f) by omitting from subsection (6) "Administrators determine" and substituting "Council determines"; (g) by omitting from subsection (8) "Administrators determine" and substituting "Council determines"; (h) by omitting from subsection (8) "they" and substituting "it"; (j) by omitting from subsection (9) "Administrators" and substituting "Council"; (k) by omitting from subsection (10) "Administrators make" and substituting "Council makes"; (m) by omitting from subsection (10) "they" and substituting "it"; (n) by omitting from subsection (11) "Administrators" and substituting "Council"; (p) by omitting from subsection (12) "Administrators" (first occurring) and substituting "Council"; (q) by omitting from subsection (12) "Administrators otherwise direct" and substituting "Council otherwise directs"; (r) by omitting from subsection (13) the definition of "Administrator". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 39 Repeal 39. Section 73BD of the Principal Act is repealed. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 40 Conduct of health benefits funds 40. Section 74B of the Principal Act is amended: (a) by omitting from paragraph (c) "and" (last occurring); (b) by inserting after paragraph (c) the following paragraph: "(ca) the Council's rules; and". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 41 Repeal of sections 76, 76A and 77 41. (1) Section 76 of the Principal Act is repealed. (2) Section 76A of the Principal Act is repealed. (3) Section 77 of the Principal Act is repealed. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 42 Changes of rules etc. by registered organisations 42. Section 78 of the Principal Act is amended: (a) by inserting in subsection (1) "in a form approved by the Minister" after "writing"; (b) by omitting subsections (1A) to (11) (inclusive) and substituting the following subsections: "(2) The notification shall: (a) identify the change; and (b) show that the change is consistent with this Act and the conditions of registration of the organisation. "(3) Where subsection (1) or (2) is not complied with in relation to a change, that change shall not be taken to have come into operation. "(4) Where the Minister is of the opinion that a change: (a) would or might result in a breach of this Act or of a condition of registration of an organisation; (b) imposes an unreasonable or inequitable condition affecting the rights of any contributors; or (c) might, having regard to the advice of the Council, adversely affect the financial stability of a health benefits fund; the Minister may, by declaration in writing, declare that the change shall not be taken to have come into operation. "(5) The Secretary shall tell the Council of any declaration made by the Minister under paragraph (4) (c). "(6) Where the Minister makes a declaration under subsection (4) in relation to a notification by an organisation, the Secretary shall tell the organisation of the declaration.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 43 Cancellation of registration of organisation 43. Section 79 of the Principal Act is amended: (a) by omitting subsection (3) and substituting the following subsection: "(3) The Minister shall cancel the registration of a registered organisation if all health benefits funds conducted by the organisation have been wound up in accordance with Part VIA."; (b) by omitting subsection (5). COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 44 Offences 44. Section 82 of the Principal Act is amended by inserting in paragraph (1) (a) "or for permission to carry on business as a registered health benefits organisation" after "organisation". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 45 45. After Part VI of the Principal Act the following Part is inserted: "PART VIAA-PRIVATE HEALTH INSURANCE ADMINISTRATION COUNCIL ''Division 1-Preliminary Interpretation "82A. In this Part, unless the contrary intention appears: 'Commissioner' means the Commissioner of Private Health Insurance Administration referred to in section 82C; 'deputy' means a deputy of a member appointed under section 82PD; 'Director' means the Director of the Council referred to in section 82PH; 'guidelines' means the guidelines referred to in section 82F; 'member' means a member of the Council and includes the Commissioner. "Division 2-Establishment and Constitution of Council Establishment ''82B. (1) There is established a Private Health Insurance Administration Council. "(2) The Council: (a) is a body corporate with perpetual succession; (b) shall have a common seal; (c) may acquire, hold and dispose of real and personal property; and (d) may sue and be sued in its corporate name. "(3) The common seal of the Council shall be kept in such custody as the Council directs and shall not be used except as authorised by the Council. "(4) All courts, judges and persons acting judicially shall take judicial notice of the imprint of the common seal of the Council appearing on a document and shall presume that it was duly affixed. Commissioner "82C. (1) There shall be a Commissioner of Private Health Insurance Administration. "(2) The Commissioner may perform the functions and exercise the powers of the Council and, where he or she performs such a function or exercises such a power, that function or power shall be taken to have been performed or exercised by the Council. "(3) The Commissioner shall, in the performance of a function or the exercise of a power of the Council, have regard, as far as is practicable, to the advice of the other members. "(4) The Commissioner shall be appointed by the Minister in accordance with the guidelines. "(5) The Commissioner shall be appointed on a full-time basis or on a part-time basis. Constitution of Council "82D. (1) The Council consists of: (a) the Commissioner; (b) 3 members representing registered organisations; and (c) one other member. "(2) The performance of the functions, or the exercise of the powers, of the Council is not affected by a vacancy or vacancies in the membership of the Council. Appointment of non-Commissioner members "82E. (1) In this section: 'member' does not include the Commissioner. "(2) The members shall be appointed by the Minister in accordance with the guidelines. "(3) A member holds office on a part-time basis. Guidelines "82F. (1) The Minister may, by written instrument, make guidelines, not inconsistent with this Part, relating to: (a) the appointment of the Commissioner, other members and deputies; (b) the terms and conditions of their offices; and (c) their periods of appointment. "(2) Before making, varying or revoking guidelines, the Minister shall consult with such registered organisations or associations of registered organisations as he or she considers appropriate. "(3) An instrument referred to in subsection (1) is a disallowable instrument for the purposes of section 46A of the Acts Interpretation Act 1901. "Division 3-Functions and powers of Council Functions "82G. The functions of the Council are: (a) to administer the Health Benefits Reinsurance Trust Fund; (b) to obtain from each registered organisation regular reports about the financial affairs of the organisation, including reports supported by actuarial certification; (c) to establish uniform standards of reporting by registered organisations to the Council; (d) to examine, from time to time, the financial affairs of registered organisations, by means of the inspection and analysis of the records, books and accounts of the organisations and any other relevant information; (e) to review, by carrying out independent actuarial assessment, the value of the assets of each health benefits fund; (f) to determine whether a registered organisation is, or is about to be, in breach of a condition referred to in section 73BAB (in this section called a 'minimum reserve condition'); (g) where the Council determines that a registered organisation is, or is about to be, in breach of a minimum reserve condition: (i) to consult with the organisation; and (ii) to make recommendations to the Minister about the action to be taken, including, where appropriate, a recommendation that the Minister apply under section 82Z for the judicial management or winding up of the fund concerned; (h) to impose levies on each registered organisation, to be calculated on the basis of the number of members of each organisation, for the purpose of meeting the: (i) general administrative costs of the Council; and (ii) administrative costs of reviews conducted by Acute Care Advisory Committees under section 3B of the Health Insurance Act 1973; (j) in the event of a registered organisation being unable to meet its liabilities to its members-to impose a levy on each other registered organisation, to be calculated on the basis of the number of their members, for the purpose of helping to meet those liabilities; (k) where it is necessary, for the purpose of making a proper examination of the financial affairs of a registered organisation, for the Council to incur unusually high costs-to impose an appropriate fee on the organisation concerned; (m) to make statistics, and other financial information, relating to a registered organisation or registered organisations, publicly available in accordance with the Council's rules; (n) to receive applications from registered organisations for review of certificates given under subsection 3B (1) of the Health Insurance Act 1973 and to refer the applications to the Secretary; (p) to impose fees in relation to applications for review of certificates given under subsection 3B (1) of the Health Insurance Act 1973; (q) to make recommendations to the Minister in relation to applications made by registered organisations under section 73BAC seeking exemption from the minimum reserve conditions; (r) to make rules, not inconsistent with this Act, for the purpose of the performance of its functions and the exercise of its powers; (s) to advise the Minister about the financial operations and affairs of registered organisations; (t) functions incidental to any other functions of the Council; and (u) any other functions conferred on the Council by this, or any other, Act. Powers "82H. The Council has power to do all things necessary or convenient to be done for, or in connection with the performance of its functions. Directions by Minister "82J. (1) The Minister may, by notice in writing to the Commissioner, give directions with respect to the performance of the Council's functions or the exercise of its powers, and the Council shall comply with any such direction. "(2) Before giving a direction under subsection (1), the Minister shall consult the Council about the proposed direction. "(3) The Minister shall cause a copy of each direction to be laid before each House of the Parliament within 15 sitting days of the House after the direction is given. Examination of records, books and accounts of registered organisations "82K. (1) Where, in the opinion of the Commissioner it is desirable, for the proper performance of the Council's functions that the records, books and accounts of a registered organisation be examined, the Commissioner may, by signed instrument, authorise: (a) the Director; (b) a member of staff of the Council; or (c) a consultant engaged by the Council; to examine and report on those records, books and accounts. "(2) The person authorised under subsection (1) shall, at all reasonable times, have full and free access to any premises in which the records, books and accounts are kept and may take extracts from, or make copies of, the records, books and accounts. "(3) The Commissioner may, by written notice given to a person who is or has been an officer, servant or agent of a registered organisation, require that person: (a) to give the Council, within the time specified in the notice, such information relating to the affairs of the registered organisation as is stated by the notice to be required; (b) to attend, at a time and place specified in the notice, before the Council and give evidence relating to the affairs of the registered organisation; or (c) to produce, at a time and place specified in the notice, all records, books and accounts in the person's custody or under the person's control relating to the affairs of the registered organisation. "(4) The Commissioner may require the information or evidence, to be given on oath and either orally or in writing and, for that purpose, the Commissioner, or a person authorised in writing by the Commissioner to do so, may administer an oath or affirmation. "(5) A person shall not: (a) refuse or fail to comply with a requirement contained in a notice served on the person under subsection (3); or (b) refuse to be sworn or to make an affirmation. Penalty: $1,000 or imprisonment for 6 months, or both. "(6) In this section: 'registered organisation' includes an organisation the registration of which was cancelled under section 79 within 12 months before the date of the notice under subsection (3). Registered organisation to give information to the Council annually "82L. (1) A registered organisation which makes any report to all or any of its members at any time after 30 June 1989, shall, within one month after making the report or within such further time as the Council allows, give a copy of the report to the Council. "(2) A registered organisation shall, within 3 months after the end of each year commencing with the year ending on 30 June 1989, or within such further time as the Council allows give to the Council: (a) such financial accounts and statements in respect of that year as the Council requires to be given for use in preparing the report referred to in section 82PA; and (b) such other statements in respect of that year as are required by the Council's rules; certified on behalf of the organisation in accordance with the Council's rules to be true and correct. Penalty: $1,000. Registered organisation to comply with Council's reporting requirements "82M. It is a condition of registration of a registered organisation that the organisation comply, within a reasonable time, with such requirements as the Council, in the performance of its functions, imposes on the organisation. "Division 4-AdministrationMeetings of Council "82N. (1) Subject to subsection (2), the Commissioner shall convene a meeting of the Council when: (a) the Commissioner thinks it necessary for the efficient performance of the Council's functions; or (b) directed to do so by written notice of the Minister. "(2) The Commissioner shall convene a meeting at least once every 6 months. "(3) The Commissioner shall determine the time and place at which a meeting is to be held. "(4) At a meeting, the Commissioner and 2 other members constitute a quorum. "(5) The Commissioner shall preside at all meetings. "(6) Questions arising at a meeting shall be determined by the Commissioner, having regard to the advice of the members present. "(7) Subject to this section, the Commissioner shall determine the procedure of the meeting. Delegation by Council "82P. The Council may, by writing under its common seal, delegate to: (a) the Director; or (b) another member of staff of the Council; all or any of the functions and powers of the Council. Annual report by Council "82PA. (1) The Council shall, as soon as practicable after 30 September in each year give the Minister a report on the operations of registered organisations during the year ending on 30 June in that year. "(2) The report shall include, in respect of each health benefits fund conducted by a registered organisation during the year to which the report relates, the following information in respect of the fund: (a) contributions payable to the fund; (b) other amounts payable to the fund; (c) fund benefits payable out of the fund; (d) management expenses; (e) other amounts payable out of the fund; (f) the balance of the fund as at the end of that year; (g) details of how the reserves of the fund have been invested; (h) such other information as the Minister requires to be included. "(3) The Minister shall lay each report under this section before each House of the Parliament within 15 sitting days of that House after it is received by the Minister. "Division 5-Offices of MembersValidity of appointments "82PB. The appointment of a person as Commissioner or as another member is not invalid because of a defect or irregularity in connection with the person's appointment. Acting Commissioner "82PC. (1) The Minister may appoint a person to act as Commissioner: (a) during a vacancy in the office of Commissioner (whether or not an appointment has been previously made to the office); or (b) during any period, or during all periods, when the Commissioner is absent from duty or from Australia or is, for any other reason, unable to perform the duties of the office; but a person appointed to act during a vacancy shall not continue to act for more than 12 months. "(2) Anything done by or in relation to a person purporting to act as Commissioner is not invalid because: (a) the occasion for the appointment had not arisen; (b) there was a defect or irregularity in connection with the appointment; (c) the appointment had ceased to have effect; or (d) the occasion for the person to act as Commissioner had not arisen or had ceased. Deputies of members "82PD. (1) The Minister may appoint a person to be the deputy of a member (other than the Commissioner) in accordance with the guidelines. "(2) The deputy of a member may attend meetings of the Council that the member does not attend and shall, while attending such a meeting, be taken to be a member. "(3) Anything done by or in relation to a deputy purporting to act under this section is not invalid because: (a) there was a defect or irregularity in connection with the appointment; or (b) the appointment had ceased to have effect. "Division 6-Conditions of Members Remuneration and allowances of members "82PE. Subject to the Remuneration Tribunal Act 1973, a member shall be paid: (a) such remuneration as is determined by the Remuneration Tribunal; and (b) such allowances as are prescribed. Resignation "82PF. A member or a deputy may resign by writing signed and given to the Minister. Termination of appointment "82PG. (1) The Minister may terminate the appointment of a member or a deputy for misbehaviour or physical or mental incapacity. "(2) If: (a) a member or a deputy becomes bankrupt, applies to take the benefit of a law for the relief of bankrupt or insolvent debtors, compounds with his or her creditors or makes an assignment of his or her remuneration for their benefit; or (b) a member of the Council is absent, except with the leave of the Commissioner, from 3 consecutive meetings of the Council; the Minister shall terminate the appointment of the member or deputy. "Division 7-Director and Staff Director "82PH. (1) There shall be a Director of the Council who shall be appointed by the Council. "(2) The Council may: (a) determine the terms and conditions of service of the Director in respect of matters not provided for by this Part; and (b) at any time terminate such an appointment. "(3) The Director holds office on a full-time basis. "(4) Subject to this section, the Director holds office for the period, and subject to the terms and conditions, specified in the instrument of appointment. "(5) A person who has attained the age of 65 years shall not be appointed as Director. "(6) A person shall not be appointed as Director for a period that extends beyond the day on which the person will attain the age of 65 years. "(7) The appointment of a person as Director is not invalid because of a defect or irregularity in connection with the person's appointment. Duties of Director "82PJ. (1) The Director shall, to the extent determined by the Council, manage the affairs of the Council. "(2) The Director shall, in managing the affairs of the Council, act in accordance with the policy of, and with any directions given by, the Council. Conflict of interests "82PK. (1) The Director shall not be present at a meeting of the Council when the Council is making a decision in relation to the office of Director. "(2) Where the Director has a direct or indirect pecuniary interest in a matter related to his or her duties as Director, he or she shall disclose the nature of the interest to the Commissioner as soon as possible after the relevant facts have come to his or her knowledge. Staff and consultants "82PL. (1) The Council may employ such staff as the Council thinks necessary to employ to assist the Council in the performance of its functions and the exercise of its powers. "(2) The Commissioner may arrange with the Secretary of a Department of the Australian Public Service for the services of officers or employees in the Department to be made available to the Council. "(3) The Council may engage, under agreements in writing, persons having suitable qualifications and experience to perform services as consultants to the Council. "(4) The terms and conditions of staff employed, or consultants engaged, by the Council are such as are determined by the Council from time to time. Remuneration and allowances of Director "82PM. Subject to the Remuneration Tribunal Act 1973, the Director shall be paid: (a) such remuneration as is determined by the Remuneration Tribunal; and (b) such allowances as are prescribed.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 46 Investigation of organisation by inspector 46. Section 82R of the Principal Act is amended by omitting paragraph (1) (a). COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 47 Application for judicial management or winding up of a fund 47. Section 82Z of the Principal Act is amended: (a) by omitting subsection (1) and substituting the following subsection: "(1) Where the Minister, after consideration of: (a) a report made under section 82W on the completion or termination of an investigation of a registered organisation; or (b) any recommendation of the Council about the action to be taken in relation to the organisation; is of the opinion that it is necessary or proper to do so, the Minister may apply to the Court for an order for the fund, or one or more of the funds, conducted by the organisation be placed under judicial management or be wound up."; (b) by omitting from paragraph (2) (b) "or" (last occurring); (c) by adding at the end of subsection (2) the following word and paragraph: "; or (d) the Council's rules.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 48 Merger of funds 48. Section 82ZP of the Principal Act is amended by omitting from subsection (1) all words from and including "proposing" to and including "Territory," and substituting: "proposing: (a) the transfer to a fund conducted by one of the organisations in a State or the Northern Territory of the business of the fund or funds conducted by the other organisation or organisations in that State or Territory; or (b) where one of the organisations has not begun to conduct a fund in a particular State or the Northern Territory-the transfer to that organisation of the business of the fund or funds conducted by the other organisation or organisations in that State or Territory; being a transfer in accordance with a scheme specified in the application.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 49 Application for review by Tribunal 49. Section 105AB of the Principal Act is amended: (a) by omitting from subsection (1A) "for registration of the organisation"; (b) by omitting subsections (5) and (6) and substituting the following subsection: "(5) An application may be made to the Tribunal for review of a decision of the Minister under subsection 78 (4).". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 50 Officers to observe secrecy 50. Section 135A of the Principal Act is amended: (a) by inserting after subsection (4) the following subsection: "(4A) Nothing in this section prohibits the Council from publishing under paragraph 82G (m) statistics or financial information relating to a registered organisation or registered organisations."; (b) by inserting after subsection (12) the following subsection: "(12A) Where information referred to in subsection (1) is information acquired in the performance of functions or duties, or in the exercise of powers, under Part VIAA, this section applies as if a reference to the Secretary were a reference to the Commissioner of the Private Health Insurance Administration Council.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 51 51. The Principal Act is amended by inserting the following section after section 138: Telephone access to offices "138A. The Minister shall direct the Secretary to make provision for the development of a service which will enable a person to make a telephone call to an office that is under the general control of the Secretary, at no greater cost than the cost of a local telephone call.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 52 Regulations 52. Section 140 of the Principal Act is amended by adding at the end the following subsection: "(2) The regulations may provide that a specified provision of the Act relating to the basic table does not apply, or applies with specified modifications, in respect of: (a) a specified registered health benefits organisation; or (b) a specified registered health benefits organisation in the conduct of its business in a specified State or in the Northern Territory.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 53 Schedule 53. (1) The Schedule to the Principal Act is amended: (a) by omitting paragraph (a) of the CONDITIONS OF REGISTRATION OF AN ORGANISATION; (b) by omitting from paragraph (l) of those conditions all words after "benefits" (first occurring) and before "who"; (c) by adding at the end of subparagraph (l) (i) "or"; (d) by omitting subparagraph (l) (ii); (e) by adding at the end of paragraph (l) of those conditions: "; and those contributors shall: (iv) only be affected by any waiting periods that applied to them for the purposes of the fund from which they transferred; and (v) have the same entitlements to benefits that they would have had if they had been members of the fund to which they transferred for the period for which they were members of the fund from which they transferred, being benefits of a kind available to members of the fund to which they transferred.". (2) The Schedule to the Principal Act is amended by omitting from paragraph (d) "of a kind referred to in paragraph (a) or (d)" and substituting "for which a benefit is payable under paragraph (a), (d), (db) or (dc)". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 54 Saving 54. A determination for the purposes of subparagraph (db) (i) or (dc) (i) of the definition of "basic private table" or "basic table" in subsection 4 (1) of the Principal Act as in force immediately before the commencement of section 21 (in this section called the "relevant definition") continues to have effect, and may be revoked, amended or varied, as if it were: (a) in the case of a determination for the purposes of subparagraph (db) (i) of the relevant definition-a determination under paragraph 4D (1) (a) of the Principal Act as amended by this Act; or (b) in the case of a determination for the purposes of subparagraph (dc) (i) of the relevant definition-a determination under paragraph 4D (1) (b) of the Principal Act as amended by this Act. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 55 Principal Act 55. In this Part, "Principal Act" means the Nursing Homes Assistance Act 1974*4*. *4* No. 147, 1974, as amended. For previous amendments, see No. 91, 1976; No. 100, 1977; No. 118, 1980; No. 118, 1981; Nos. 26 and 80, 1982; No. 139, 1983; No. 63, 1984; Nos. 24, 52 and 65, 1985; No. 115, 1986; and No. 72, 1987. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 56 Interpretation 56. Section 3 of the Principal Act is amended: (a) by inserting in the definition of "nursing home care" in subsection (1) ", personal care" after "accommodation"; (b) by inserting in subsection (1) the following definition: " 'personal care' means assistance of a personal nature given to help a person attend to his or her daily needs or carry out his or her daily routine;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 57 Approval in principle of nursing home etc. 57. Section 3A of the Principal Act is amended by inserting after subsection (3) the following subsection: "(3A) After the commencement of this subsection, the Minister shall not give a certificate under subsection (2) or (3).". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 58 Approval of nursing home 58. Section 4 of the Principal Act is amended: (a) by omitting from subparagraph (6) (c) (i) "or"; (b) by inserting after subparagraph (6) (c) (i) the following subparagraph: "(ia) ensuring that, to the extent that the principles and objectives formulated by the Minister under section 5 of the Disability Services Act 1986 are applicable in relation to the provision to qualified nursing home patients in the nursing home of: (A) nursing home care; or (B) any services that, as specified in the agreement entered into under section 15 by the Commonwealth with the proprietor of the nursing home, are to be provided for qualified nursing home patients in the nursing home; that care and those services are provided in a manner that furthers those principles and objectives; or"; (c) by adding at the end the following subsections: "(13) Subject to subsection (14), the Minister shall not, after the commencement of this subsection, grant an approval under this section. "(14) The Minister may, not later than 30 June 1992, on application made under subsection (1), grant an approval under this section if: (a) the applicant is the holder of a certificate in force under section 3A in respect of the premises to which the application relates; or (b) the application relates to premises in respect of which an approval previously granted under this section is in force at the time when the application is made. "(15) After the commencement of this subsection, the Minister may not determine under subsection (10) a period ending after 30 June 1992. "(16) If, before the commencement of this subsection, the Minister had determined under subsection (10) a period ending after 30 June 1992, the period so determined shall, for the purposes of this Act, be taken to be a period ending at the end of 30 June 1992.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 59 Application of National Health Act 59. Section 5 of the Principal Act is amended: (a) by omitting from paragraph (1) (a) "and" (last occurring); (b) by inserting after paragraph (1) (a) the following paragraph: "(ab) section 40AB of the National Health Act 1953 has also effect after the commencement of this paragraph as if: (i) any reference in subsections (2) and (3) to a person's needing or requiring nursing care by reason of infirmity or illness, disease, incapacity or disability were a reference to that person's needing or requiring nursing care or personal care by reason of that person's condition as a disabled person; and (ii) subsection (4) were omitted and the following subsection substituted: '(4) The Minister shall not approve an application under subsection (3) on behalf of a patient if the Minister is satisfied that: (a) having regard to the medical condition of the patient and to any other relevant circumstances, the needs of the patient would be adequately, and more suitably, provided for in a place other than an approved nursing home; and (b) accommodation in such a place is available to the patient'; and". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 60 Approval of additional services 60. Section 6 of the Principal Act is amended: (a) by omitting paragraph (4) (b) and substituting the following paragraph: "(b) any other conditions determined by the Minister for the purpose of ensuring: (i) that the needs of persons of that class who seek the services are satisfactorily provided for; or (ii) that, to the extent that the principles and objectives formulated by the Minister under section 5 of the Disability Services Act 1986 are applicable to the provision of those services for persons of that class, the services are provided in a manner that furthers those principles and objectives."; (b) by adding at the end the following subsection: "(7) At the end of 30 June 1992, any approval then in force under this section ceases to be in force.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 61 Common form of nursing home agreement 61. Section 12 of the Principal Act is amended: (a) by omitting subsection (1A) and substituting the following subsection: "(1A) In this section: 'adjusted deficit', in relation to the proprietor of an approved nursing home, in respect of a year or any other period, means the amount obtained by deducting from the amount that, under subsection (4), is the approved deficit of the proprietor in respect of that year or other period any approved expenditure by the proprietor in respect of that year or other period that is of one of the following kinds: (a) expenditure on the replacement of an asset of the nursing home exceeding $1,200 in value; (b) expenditure exceeding $1,200 on repairs, or maintenance work, carried out on an asset of the nursing home; (c) contributions paid to a superannuation scheme on behalf of persons employed by the proprietor for the purposes of the nursing home; (d) payments in respect of long service leave entitlements of persons referred to in paragraph (c); 'approved expenditure', in relation to the proprietor of a nursing home, means expenditure in accordance with particulars of expenditure or expected expenditure approved by the Secretary under the agreement relating to the nursing home entered into with the proprietor under section 15; 'relevant association' means an association that: (a) represents eligible organisations; and (b) is specified by the Minister by notice in writing published in the Gazette as a relevant association for the purposes of this section."; (b) by omitting from subsection (4) "an amount" and substituting ", if subsection (4A) does not apply, the amount"; (c) by inserting in subsection (4) "(including approved services)" after "other services" (first occurring); (d) by inserting after subsection (4) the following subsections: "(4A) If the adjusted deficit of the proprietor of a nursing home in respect of a year, or other period, ending after 30 June 1989 is more than the amount that, under subsection (4B), is the prescribed amount in relation to the proprietor in respect of that year or period: (a) the amount of the difference between that adjusted deficit and that prescribed amount shall be deducted from the amount that, under subsection (4), is the approved deficit of the proprietor in respect of that year or period; and (b) the amount obtained shall, for the purposes of this Act, be taken to be the approved deficit of the proprietor in respect of that year or period. "(4B) The prescribed amount in relation to the proprietor of an approved nursing home in respect of a year, or other period, ending after 30 June 1989 (in this subsection called the 'later year' and 'later period' respectively) is: (a) if the average number of beds occupied per day by qualified nursing home patients in the nursing home during the later year or later period is less than the average number of beds occupied per day by qualified nursing home patients in the nursing home during the year, or (if applicable) other period approved by the Secretary under paragraph (2) (a), ending on 30 June 1989: (i) the amount calculated by using the formula: AD - EAS ANB1 X ANB2 + EAS where: AD is the adjusted deficit of the proprietor in respect of the year, or other period, ending on 30 June 1989; EAS is so much of the approved expenditure of the proprietor on the provision of approved services at the nursing home in respect of the year, or other period, ending on 30 June 1989 that is not expenditure of a kind referred to in paragraphs (a), (b), (c) and (d) of the definition of 'adjusted deficit' in subsection (1A); ANB1 is the average number of beds occupied per day by qualified nursing home patients in the nursing home during the year, or other period, ending on 30 June 1989; and ANB2 is the average number of beds occupied per day by qualified nursing home patients in the nursing home during the later year or later period; or (ii) if a determination under subsection (4C) is in force-the amount calculated under subparagraph (i) increased in the manner set out in the determination; or (b) if paragraph (a) does not apply: (i) the amount equal to the adjusted deficit of the proprietor in respect of the year, or (if applicable) other period approved by the Secretary under paragraph (2) (a), ending on 30 June 1989; or (ii) if a determination under subsection (4C) is in force-the amount referred to in subparagraph (i) increased in the manner set out in the determination. "(4C) If the Minister, having regard to relevant economic indicators, is satisfied that prescribed amounts under subsection (4B) in respect of a year, or other period, ending after 30 June 1989 should be higher than amounts obtained under subparagraph (4B) (a) (i) or (b) (i), the Minister may, by written notice, determine that, in determining prescribed amounts under subsection (4B) in respect of that year or other period, any amount obtained under either of those subparagraphs should be increased in the manner set out in the determination.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 62 Certain notices to be subject to disallowance 62. Section 36A of the Principal Act is amended by inserting in subsection (1) "12 (4C) or" after "subsection". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 63 Principal Act 63. In this Part, "Principal Act" means the Remuneration Tribunal Act 1973*5*. *5* No. 215, 1973, as amended. For previous amendments, see No. 80, 1974; No. 96, 1975; Nos. 60 and 178, 1978; Nos. 26, 108, 136 and 155, 1979; No. 160, 1980; Nos. 61, 74 and 176, 1981; Nos. 78 and 111, 1982; Nos. 39 and 128, 1983; Nos. 63, 73 and 164, 1984; Nos. 65 and 187, 1985; and Nos. 87, 109 and 123, 1988. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 64 Inquiries and determinations by Tribunal 64. (1) Section 7 of the Principal Act is amended: (a) by omitting from paragraph (9) (ac) "and"; (b) by inserting after paragraph (9) (ac) the following paragraphs: "(ad) in the case of remuneration or allowances payable to a person who holds the office of Commissioner of Private Health Insurance Administration, an office of member of the Private Health Insurance Administration Council or the office of Director of that Council-to be paid in accordance with the determination out of funds under the control of that Council; (ae) in the case of remuneration or allowances payable to a person who holds an office of member of the Acute Care Advisory Committee or an Acute Care Advisory Committee-to be paid in accordance with the determination out of funds under the control of the Private Health Insurance Administration Council; and". (2) The amendment made by this section only applies in relation to Acute Care Advisory Committees established after the commencement of section 9 of this Act. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 65 Principal Act 65. In this Part, "Principal Act" means the States Grants (Nurse Education Transfer Assistance) Act 1985*6*. *6* No. 164, 1985, as amended. For previous amendments, see No. 75, 1986; No. 132, 1987; and Nos. 79 and 80, 1988. COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 66 Interpretation 66. Section 3 of the Principal Act is amended by inserting in subsection (1) the following definitions: " 'first census day' means: (a) 31 March; or (b) if any other day is prescribed for the purposes of this paragraph-that other day; 'second census day' means: (a) 31 August; or (b) if any other day is prescribed for the purposes of this paragraph-that other day;". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 67 Special nurse education transfer grants 67. Section 4 of the Principal Act is amended: (a) by omitting from subparagraph (3) (c) (i) "30 April" and substituting "the first census day"; (b) by omitting from subparagraph (3) (c) (ii) "30 September" and substituting "the second census day". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SECT 68 68. The Principal Act is amended by adding at the end the following section: Regulations "10. The Governor-General may make regulations, not inconsistent with this Act, prescribing all matters required or permitted by this Act to be prescribed.". COMMUNITY SERVICES AND HEALTH LEGISLATION AMENDMENT ACT 1989 No. 95 of 1989 - SCHEDULE SCHEDULE Section 18 NEW SCHEDULE 1A TO THE HEALTH INSURANCE ACT 1973 SCHEDULE 1A PATHOLOGY SERVICES TABLE RULES FOR INTERPRETATION OF THE PATHOLOGY SERVICES TABLE 1. In this Schedule: "recognised pathologist" means a medical practitioner who, by reason of a determination under section 61, is recognised for the purposes of this Act as a specialist in the speciality of pathology. 2. Where an item includes the symbol "(SP)", the item relates to a pathology service when rendered by or on behalf of an approved pathology practitioner who is a recognised pathologist other than a pathology service: (a) rendered pursuant to a request made in the course of the provision of an out-patient service at a recognised hospital; (b) rendered pursuant to a request made in respect of a person who was, at the time when the request was made, a private patient in a recognised hospital; or (c) in the rendering of which: (i) any pathology equipment of a recognised hospital, or a laboratory included in a prescribed class of laboratories, is used; or (ii) any member of the staff of a recognised hospital, or a laboratory included in a prescribed class of laboratories, participates in the course of that member's employment with that hospital or laboratory. 3. Where an item includes the symbol "(OP)", the item shall be taken to relate to a pathology service other than a pathology service: (a) to which an item that includes the symbol "(SP)" relates; or (b) to which sub-section 16A (7) applies. 4. For the purposes of rules 2 and 3 each of the following classes of laboratories is a prescribed class of laboratories: (a) laboratories operated by the Commonwealth; (b) laboratories operated by a State or an authority of a State; (c) laboratories operated by the Northern Territory of Australia; (d) laboratories operated by the Australian Capital Territory Community and Health Service; and (e) laboratories operated by an Australian tertiary institution. 5. Two or more pathology services rendered pursuant to 2 or more requests shall be taken to have been rendered pursuant to a single request if: (a) each pathology service is rendered to the same person; (b) each pathology service is of a kind listed in the one item of the table; and (c) the determinations of the necessity for the pathology services were made on the same day. 6. In rule 5, "service" includes an assay, estimation or test. 7. A reference in these rules to a request made to an approved pathology practitioner includes a reference to a request that is deemed, for the purposes of section 16A, to have been made to that approved pathology practitioner. 8. Where: (a) a pathology service (the 'first pathology service') is rendered pursuant to a request; (b) an item of the table applies to that pathology service; (c) another pathology service (the 'second pathology service') is rendered pursuant to the request; and (d) the second pathology service is of a kind referred to in the item referred to in paragraph (b); the second pathology service shall be treated as if it were completely subsumed within the first pathology service. Example: Dr Proctor requests an extended blood grouping test (covered by item 1192) and the test includes a basic blood grouping test (covered by item 1187). Item 1187 is referred to in item 1192. Benefit is payable under item 1192 for the extended blood grouping test but benefit is not payable separately under item 1187 for the basic blood grouping test. 9. For the purposes of Division 1-Haematology: (a) if pathology services of a kind referred to in item 1187, 1188, 1192 or 1193 are rendered to a person during a period of hospitalisation, the item applies only to the first pathology service of that kind rendered to the person during that person's hospitalisation; and (b) tests performed on material stored from a previous patient episode (except tests specified in item 1198 or 1199) in response to a subsequent request are treated as being part of that previous patient episode if the second request is made within 14 days of that previous patient episode. 10. For the purposes of Division 2-Chemical Pathology: (a) where a pathology service involving the measurement of any substance in urine requires a 24 hour urine collection and/or calculation of a substance/creatinine ratio, that pathology service is treated as including any estimation of creatinine in other fluids necessary for calculation; and (b) tests performed on material stored from a previous patient episode in response to a subsequent request are treated as being part of that previous patient episode if the second request occurs within 14 days of that previous patient episode. 11. For the purposes of Division 3-Microbiology: (a) serial examinations or cultures means examinations or cultures requested on the one occasion regardless of whether the materials are received on different days by the approved pathology practitioner and regardless of whether the examinations or cultures were requested on one or more request forms by the treating practitioner; and (b) tests performed on material which has been stored from a previous patient episode in response to a subsequent request are treated as being part of that previous patient episode if the further request occurs within 14 days of that previous patient episode. 12. For the purposes of Division 4-Immunology: (a) tests performed on material which has been stored from a previous patient episode in response to a subsequent request are treated as being part of that previous patient episode if the further request occurs within 14 days of that previous patient episode; and (b) in items 2271, 2274, 2275, 2276, 2277, 2278, 2279 and 2280, the estimation of a single antibody includes qualitative and quantitative assays for that antibody. 13. For the purposes of Division 5-Histopathology: (a) "biopsy material" means all tissue received by the approved pathology practitioner from any operation or group of operations performed on a patient at the one time other than a bone marrow biopsy; and (b) where a pathology service relating to the examination of biopsy material is rendered under an item set out in Division 5 in circumstances where a further pathology service or pathology services specified in an item or items in Division 5 are rendered also in relation to that biopsy material, all those pathology services are treated as one pathology service rendered under the one item appropriate to the pathology services provided. 14. For the purposes of Division 6-Cytopathology, "serial examinations" means examinations requested on the one occasion regardless of whether the materials are received on different days by the approved pathology practitioner and regardless of whether the examinations were requested on one or more request forms by the treating practitioner. 15. Where in these rules provision is made for 2 or more pathology services to be treated as one pathology service, a reference to an appropriate item is a reference to the item which incorporates whichever of the symbols (SP) or (OP) is relevant to the rendering of that pathology service. 16. The lists of abbreviations at the end of the table are provided to allow users of the table to identify and refer to particular pathology services, or particular groups of pathology services, more accurately and more conveniently. ------------------------------------------------------------------------------ -- Item No. Pathology Service Fees- All States ------------------------------------------------------------------------------ -- $ Division 1-Haematology 1163 Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haemoglobin, platelet count, leucocyte count, reticulocyte count-one or two procedures. SP 7.35 1164 Blood count consisting of erythrocyte count, C-reactive protein, erythrocyte sedimentation rate, blood viscosity, haemoglobin, platelet count, leucocyte count, reticulocyte count-one or two procedures. OP 5.55 1168 Three or more procedures to which item 1163 applies, including any calculation or measurement of erythrocyte or other indices. SP 10.00 1169 Three of more procedures to which item 1164 applies, including any calculation or measurement of erythrocyte or other indices. OP 7.50 1170 Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and the performance of any of these additional services-Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1419. SP 13.20 1171 Examination of blood film, with or without differential cell count, or differential cell count with or without examination of blood film, and the performance of any of these additional services-Direct Coombs test, tests for heterophile antibodies, cold agglutinins, examination of blood film by special stains to demonstrate Heinz bodies, parasites or iron, or examination of a blood film with alpha-naphthyl acetate esterase, choloroacetate esterase, neutrophil alkaline phosphotase, nitro blue tetrazolium, periodic acid Schiff, Sudan Black stains, or Kleihauer test for HbF on blood film, including any services specified in item 1420. OP 9.90 1172 Full blood examination consisting of items 1168 and 1170. SP 23.00 1173 Full blood examination consisting of items 1169 and 1171. OP 17.25 1176 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by-erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine-one or more procedures. SP 30.50 1177 Erythrocytes, qualitative or quantitative assessment of haemolysis or metabolic enzymes by-erythrocyte autohaemolysis test, erythrocyte fragility test, sugar water test, erythrocyte metabolic enzyme test, heat denaturation test, isopropanol precipitation test, acid haemolysis test, and quantitation of muramidase in serum or urine-one or more procedures. OP 22.90 1179 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the following-examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 1163, 1168, 1170 and 1172. SP 47.50 1180 Tests for the diagnosis of haemoglobinopathy consisting of haemoglobin electrophoresis and two of the following-examination for HbH, quantitation of HbA2 or HbF, including any services specified in items 1164, 1169, 1171 and 1173. OP 35.65 1181 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any services specified in items 1163, 1168, 1170, 1172 and 1183. SP 146.00 1182 Histopathological examination of sections of bone marrow trephine biopsy including where indicated, examination of marrow smears and any special stains and immuno-chemical techniques, including any services specified in items 1164, 1169, 1171, 1173 and 1184. OP 109.50 1183 Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any services specified in items 1163, 1168, 1170 and 1172. SP 106.00 1184 Bone marrow examination of aspirated material including any special stains, immuno-chemical techniques and clot sections where necessary, including any services specified in items 1164, 1169, 1171 and 1173. OP 79.50 1187 Blood grouping, including back-grouping when performed-ABO and Rh (D antigen). SP 12.80 1188 Blood grouping, including back-grouping when performed-ABO and Rh (D antigen). OP 9.60 1192 Blood grouping-Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-one or more systems, including any services specified in item 1187. SP 25.50 1193 Blood grouping-Rh phenotypes, Kell system, Duffy system, M and N factors or any other blood group system-one of more systems, including any services specified in item 1188. OP 19.15 1196 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1163, 1168, 1170 and 1172. SP 47.50 1197 Blood grouping, including back-grouping when performed, and examination of serum for Rh and other blood group antibodies, including identification and quantitative estimation of any antibodies detected, and including any services specified in items 1164, 1169, 1171 and 1173. OP 35.65 1198 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 1163, 1168, 1170, 1172, 1187 and 1196 including all testing performed on any one day. SP 116.00 1199 Compatibility testing, including all necessary grouping checks of patient and donor, examination for antibodies, identification and, if necessary, quantitative estimation of any antibodies detected and any services specified in items 1164, 1169, 1171, 1173, 1188 and 1197 including all testing performed on any one day. OP 87.00 1417 Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected. SP 21.00 1418 Examination of serum for blood group antibodies including identification and, if necessary, quantitative estimation of any antibodies detected. OP 15.75 1419 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) excluding those services specified in items 1170 and 1173-one or more tests. SP 11.60 1420 Direct Coombs test, qualitative or quantitative test for cold agglutinins, or heterophile antibodies, qualitative spectroscopic examination of blood for abnormal haemoglobins, qualitative test for red cell porphyrins and detection of metalbumin (Schumm's test) excluding those services specified in items 1171 and 1173-one or more tests. OP 8.70 1521 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one of-fibrinogen degradation products, fibrin monomer or D-dimer-one estimation. SP 16.00 1522 Skin bleeding time, coagulation time, prothrombin time, activated partial thromboplastin time, thrombin time (including test for presence of an inhibitor and serial tests for fibrinolysis), test for factor XIII deficiency, fibrinogen, or one of-fibrinogen degradation products, fibrin monomer or D-dimer-one estimation. OP 12.00 1523 Two estimations specified in item 1521. SP 21.00 1524 Two estimations specified in item 1522. OP 15.75 1525 Three estimations specified in item 1521. SP 26.50 1526 Three estimations specified in item 1522. OP 19.90 1527 Four or more estimations specified in item 1521. SP 31.50 1528 Four or more estimations specified in item 1522. OP 23.65 1531 Quantitative assay, by one or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant-one estimation. SP 31.50 1532 Quantitative assay, by one or more techniques, of plasminogen, antithrombin III, Protein C, Protein S, heparin co-factor II, Euglobulin clot lysis time and test for lupus anticoagulant-one estimation. OP 23.65 1533 Four or more estimations specified in item 1531. SP 100.00 1534 Four or more estimations specified in item 1532. OP 75.00 1535 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance-one or more estimations. SP 63.00 1538 Platelet aggregation in response to ADP, collagen, 5HT, ristocetin or similar substance-one or more estimations. OP 47.25 1539 Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin-one or more estimations. SP 42.00 1540 Heparin assay, only when monitoring a patient on subcutaneous heparin or low molecular weight heparin-one or more estimations. OP 31.50 1541 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor-one estimation. SP 42.00 1542 Quantitative assay of Von Willebrand's factor antigen (factor VIII related antigen), Von Willebrand's factor (ristocetin cofactor), factor II, factor V, factor VII, factor VIII, factor IX, factor X, factor XI, factor XII, factor XIII, Fletcher factor, Fitzgerald factor, Passovy factor-one estimation. OP 31.50 1543 Two estimations as specified in item 1541. SP 63.00 1544 Two estimations as specified in item 1542. OP 47.25 1550 Three or more estimations as specified in item 1541. SP 79.00 1551 Three or more estimations as specified in item 1542. OP 59.25 Division 2-Chemical pathology 1558 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of-alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1734), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea-one estimation. SP 13.20 1559 Quantitative estimation in serum, plasma, urine or any other body fluid, by any method except by reagent strip with or without reflectance meter or electrophoresis of-alanine amino-transferase, albumin, alkaline phosphatase, amylase, aspartate aminotransferase, bicarbonate, bilirubin (total and any fractions), calcium (total, dialysed or ionized), chloride, cholesterol, creatine kinase, creatine kinase isoenzymes (when not performed as specified in item 1735), creatinine, fructosamine, gamma glutamyl transpeptidase, globulin, glucose, lactate dehydrogenase, lipase, lithium, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urate, urea-one estimation. OP 9.90 1560 Two estimations specified in item 1558. SP 16.00 1561 Two estimations specified in item 1559. OP 12.00 1562 Three estimations specified in item 1558. SP 18.60 1563 Three estimations specified in item 1559. OP 13.95 1564 Four estimations specified in item 1558. SP 21.00 1565 Four estimations specified in item 1559. OP 15.75 1569 Five estimations specified in item 1558. SP 23.50 1570 Five estimations specified in item 1559. OP 17.65 1571 Six or more estimations specified in item 1558. SP 26.50 1572 Six or more estimations specified in item 1559. OP 19.90 1575 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents-bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum-one or more estimations. SP 12.60 1576 Qualitative estimation by any method, except by reagent strip or dip-stick of the following urine constituents-bilirubin, cystine (cysteine), haemoglobin, melanin (melanogen), myoglobin, porphobilinogen, porphyrins, urobilinogen or pH measurement of body fluids other than urine (excepting urine acidification test), or cryoglobulins or cryofibrinogen in serum-one or more estimations. OP 9.45 1577 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents-haemoglobin, porphyrins, reducing substances-each estimation, to a maximum of three estimations, taken on separate days. SP 8.40 1578 Qualitative estimation by any method except by reagent strip or dip-stick of the following faecal constituents-haemoglobin, porphyrins, reducing substances-each estimation, to a maximum of three estimations, taken on separate days. OP 6.30 1579 Immunological test for human haemoglobin in faeces performed in any twenty eight day period, including chemical test if performed-one estimation-SP 16.00 1580 Immunological test for human haemoglobin in faeces performed in any twenty eight day period, including chemical test if performed-one estimation. OP 12.00 1581 Two or more estimations specified in item 1579. SP 36.50 1582 Two or more estimations specified in item 1580. OP 27.40 1583 Osmolality, estimation by osmometer, in serum or in urine-one or more estimations. SP 31.50 1584 Osmolality, estimation by osmometer, in serum or in urine-one or more estimations. OP 23.65 1590 Quantitative estimation of blood gases including tests performed from-pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments-one or more estimation on one specimen. SP. 43.00 1591 Quantitative estimation of blood gases including tests performed from-pO2, oxygen saturation, pCO2, bicarbonate, pH, and any other measurement (eg. haemoglobin, potassium) or calculation performed on the same specimen by the same instrument or group of instruments-one or more estimation on one specimen. OP. 32.25 1592 One or more estimations of blood gases as specified in item 1590 on two or more specimens within any one day. SP 53.00 1593 One or more estimations of blood gases as specified in item 1591 on two or more specimens within any one day. OP 39.75 1595 Calculus, analysis of one or more. SP 39.00 1596 Calculus, analysis of one or more. OP 29.25 1598 Drug or chemical assays-including all qualitative and quantitive tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 1712, 1714 and 1716, but excluding the surveillance of sports people and athletes for performance improving substances-one or more assays. SP 53.00 1599 Drug or chemical assays-including all qualitative and quantitive tests on blood, urine or other body fluid for a drug or drugs of abuse, including illegal drugs and legally available drugs taken other than in appropriate dosage, ingested or absorbed toxic chemicals including any services specified in items 1713, 1715 and 1717, but excluding the surveillance of sports people and athletes for performance improving substances-one or more assays. OP 39.75 1627 Drug assays-including all qualitative and quantitive estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs-each assay to a maximum of four assays within any twenty eight day period. SP 26.50 1628 Drug assays-including all qualitative and quantitive estimations on blood, urine or other body fluid for a drug or drugs of abuse or a therapeutic drug on a sample collected from a patient participating in a drug abuse treatment programme, or being treated for drug effects or under a court order or parole board supervision, but excluding the detection of nicotine and metabolites in smoking withdrawal programs-each assay to a maximum of four assays within any twenty eight day period. OP 19.90 1712 Drug assay-quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents)-one estimation. SP 26.50 1713 Drug assay-quantitative estimation on blood or other body fluid by any method or methods of a drug being used therapeutically for the patient from whom the specimen was taken (excluding antibiotics or antimicrobial chemotherapeutic agents)-one estimation. OP 19.90 1714 Two estimations specified in item 1712. SP 36.50 1715 Two estimations specified in item 1713. OP 27.40 1716 Three or more estimations specified in item 1712. SP 47.50 1717 Three or more estimations specified in item 1713. OP 35.65 1726 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid-one or more examinations or estimations. SP 42.00 1727 Amniotic fluid, spectrophotometric examination of, estimation of lecithin/sphingomyelin ratio or palmitic acid-one or more examinations or estimations. OP 31.50 1734 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase, including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity, but excluding lipoprotein electrophoresis-one examination. SP 39.00 1735 Electrophoresis, quantitative or qualitative of serum, urine or other body fluid to demonstrate protein classes or presence and amount of paraprotein, or the isoenzymes of lactate dehydrogenase, alkaline phosphatase and creatine kinase, including the preliminary quantitation of total protein, albumin and globulin or of total relevant enzyme activity, but excluding lipoprotein electrophoresis-one examination. OP 29.25 1736 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum and urine to demonstrate protein classes or presence and amount of paraproteins, including the preliminary quantitation of total protein, albumin and globulin, but excluding lipoprotein electrophoresis-two or more examinations. SP 58.00 1737 Electrophoresis, quantitative or qualitative of concurrently collected, or collected within a twenty eight day period, serum and urine to demonstrate protein classes or presence and amount of paraproteins, including the preliminary quantitation of total protein, albumin and globulin, but excluding lipoprotein electrophoresis-two or more examinations. OP 43.50 1738 Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1752), Haptoglobins, Microalbumin (in proven diabetes mellitus), Transferrin (unless specified in item 1752) and, in the follow up of proven malignancy, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Prostatic Acid Phosphatase (one or more fractions), Prostate specific antigen-quantitative estimation in serum, urine or other body fluid-one estimation. SP 25.50 1739 Alpha-feto protein, Alpha-1 antitrypsin, Alpha-2 macroglobulin, beta-2 microglobulin, C-1 esterase inhibitor, Caeruloplasmin, Ferritin (unless specified in item 1753), Haptoglobins, Microalbumin (in proven diabetes mellitus), Transferrin (unless specified in item 1753) and, in the follow up of proven malignancy, CA-125 antigen, CA-19.9 antigen, CA-15.3 antigen, Carcinoembryonic antigen, Prostatic Acid Phosphatase (one or more fractions), Prostate specific antigen-quantitative estimation in serum, urine or other body fluid-one estimation. OP 19.15 1740 Two or more estimations specified in item 1738. SP 47.50 1741 Two or more estimations specified in item 1739. OP 35.65 1752 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin. SP 50.00 1753 Iron studies consisting of quantitative analysis of iron, transferrin or iron binding capacity and ferritin. OP 37.50 1768 Serum B12, serum folate-one or more estimations within any twenty eight day period. SP 31.50 1769 Serum B12, serum folate-one or more estimations within any twenty eight day period. OP 23.65 1770 Red cell folate and serum B12 and, if required, serum folate, to a maximum of three estimations in any twelve month period. SP 57.50 1771 Red cell folate and serum B12 and, if required, serum folate, to a maximum of three estimations in any twelve month period. OP 43.00 1780 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E-one or more estimations within any six month period. SP 39.00 1783 Vitamins, quantitative estimation in blood, urine or other body fluid, by direct or indirect means, of Vitamins A, B1, B2, B3, B6, C, and E-one or more estimations within any six month period. OP 29.25 1786 Vitamin D or D fractions-one or more estimations. SP 39.00 1787 Vitamin D or D fractions-one or more estimations. OP 29.25 1791 Alcohol, ammonia, angiotensin converting enzyme, neonatal bilirubin (one or more fractions), cholinesterase, cystine (cysteine), hydroxyindoleacetic acid, hydroxyproline, lactate, pyruvate, oxalate, xylose, zinc-one quantitative estimation. SP 31.50 1792 Alcohol, ammonia, angiotensin converting enzyme, neonatal bilirubin (one or more fractions), cholinesterase, cystine (cysteine), hydroxyindoleacetic acid, hydroxyproline, lactate, pyruvate, oxalate, xylose, zinc-one quantitative estimation. OP 23.65 1795 Two or more estimations specified in item 1791. SP 49.50 1798 Two or more estimations specified in item 1792. OP 37.15 1871 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium-in blood, urine or other body fluid or tissue-one or more estimations within any six month period. SP 44.50 1872 Aluminium, arsenic, beryllium, cadmium, copper, chromium, gold, manganese, mercury, nickel, selenium, strontium-in blood, urine or other body fluid or tissue-one or more estimations within any six month period. OP 33.40 1895 Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month period-each estimation. SP 39.00 1896 Blood lead estimation, other than for occupational health screening purposes, to a maximum of three estimations in any six month period-each estimation. OP 29.25 1959 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA)-quantitative including any qualitative estimations-one or more estimations. SP 51.00 1960 Porphyrins (one or more fractions), Catecholamines (one or more fractions), Hydroxy Methoxy Mandelic Acid (HMMA), Homovanillic Acid (HVA), Methoxy Hydroxy Phenylethylene Glycol (MHPG), Phenyl Acetic Acid (PAA)-quantitative including any qualitative estimations-one or more estimations. OP 38.25 1963 Faecal fat-one or more quantitative estimations within any twenty eight day period. SP 51.00 1964 Faecal fat-one or more quantitative estimations within any twenty eight day period. OP 38.25 1969 Solid tissue or tissues excluding blood elements-assay of one or two enzymes. SP 51.00 1970 Solid tissue or tissues excluding blood elements-assay of one or two enzymes. OP 38.25 1975 Assay of three to five enzymes as specified in item 1969. SP 95.00 1976 Assay of three to five enzymes as specified in item 1970. OP 71.25 1977 Assay of six or more enzymes as specified in item 1969. SP 126.00 1978 Assay of six or more enzymes as specified in item 1970. OP 94.50 1983 Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following tests-free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin. SP 53.00 1984 Thyroid function tests, including thyrotrophin (TSH) and at least one or more of the following tests-free thyroxine index, free thyroxine, free T3, total T3, thyroxine binding globulin. OP 39.75 1985 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. SP 63.00 1986 Thyrotrophin releasing hormone (TRH) test, including provision and administration of TRH and all necessary estimations of hormones. OP 47.25 2021 Hormones and hormone binding proteins, quantitative estimation by any method of-ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone)-one estimation. SP 36.50 2024 Hormones and hormone binding proteins, quantitative estimation by any method of-ACTH, Aldosterone, Androstenedione, C-peptide, Calcitonin, Cortisol, Cyclic AMP, DHEAS, FSH, Gastrin, Growth hormone, Hydroxyprogesterone, Insulin, LH, Oestradiol, Oestriol, Oestrone, Progesterone, Prolactin, PTH, Renin, Sex hormone binding globulin, Somatomedin C(IgF1), free or total Testosterone, Urine steroid fraction or fractions, Vasoactive intestinal peptide, Vasopressin (anti diuretic hormone)-one estimation. OP 27.40 2025 Two estimations specified in item 2021. SP 58.00 2026 Two estimations specified in item 2024. OP 43.50 2027 Three estimations specified in item 2021. SP 73.00 2028 Three estimations specified in item 2024. OP 54.75 2029 Four estimations specified in item 2021. SP 89.00 2030 Four estimations specified in item 2024. OP 66.75 2031 Five estimations specified in item 2021. SP 100.00 2032 Five estimations specified in item 2024. OP 53.45 2033 Six or more estimations specified in item 2021. SP 112.00 2034 Six or more estimations specified in item 2024. OP 84.00 2037 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma-one or more assays. SP 102.00 2038 Hormone receptor assay on proven primary breast carcinoma or subsequent lesion in the breast or metastasis from a breast carcinoma-one or more assays. OP 76.50 2039 HDL cholesterol, estimation of, in patients, with serum cholesterol >5.5mmol/1-each estimation to a maximum of four estimations in any twelve month period. SP 16.00 2040 HDL cholesterol, estimation of, in patients, with serum cholesterol >5.5mmol/1-each estimation to a maximum of four estimations in any twelve month period. OP 12.00 2043 Glycosylated haemoglobin only when performed in the management of established diabetes-each estimation to a maximum of four estimations in any twelve month period. SP 21.50 2044 Glycosylated haemoglobin only when performed in the management of established diabetes-each estimation to a maximum of four estimations in any twelve month period. OP 16.15 Division 3-Microbiology 2083 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultures-wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, of stained preparation or preparations using any relevant stain or stains-one or more examinations. SP 9.50 2084 Microscopic examination including serial examinations of material other than blood, from one or more sites, obtained directly from a patient and excluding material from cultures-wet film, including differential cell count if performed, examination for dermatophytes or dark ground illumination, or stained preparation or preparation using any relevant stain or stains-one or more examinations. OP 7.15 2085 Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 2083-each estimation. SP 16.00 2086 Microscopic examination of faeces for parasites using concentration techniques including the use of appropriate stains, to a maximum of three estimations taken on separate days including any services specified in item 2084-each estimation. OP 12.00 2087 The cultural examination and miscroscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 2083, 2089 and 2098-one or more sites. SP 25.00 2088 The cultural examination and miscroscopical examination when indicated (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from nasal swabs, throat swabs, eye swabs and ear swabs, including pathogen identification and antibiotic sensitivity testing, including any services specified in item 2084, 2090 and 2099-one or more sites. OP 18.75 2089 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites-skin or other superficial sites, urethral, vaginal, cervical, sputum (except when part of item 2119) and rectal (except for faecal pathogens), including pathogenic identification and antibiotic sensitivity testing, including any services specified in item 2083, 2087 and 2098-one or more sites. SP 36.50 2090 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) to determine the presence of pathogenic micro-organisms, including fungi but excluding viruses, from the following sites-skin or other superficial sites, urethral, vaginal, cervical, sputum (except when part of item 2120) and rectal (except for faecal pathogens), including pathogenic identification and antibiotic sensitivity testing, including any services specified in item 2084, 2088 and 2099-one or more sites. OP 27.40 2098 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in item 2083, 2087 and 2089-one or more sites. SP 49.50 2099 Microscopical and cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of post-operative wounds, aspirations of body cavities, synovial fluid CSF and operative or biopsy specimens for the presence of pathogenic micro-organisms, including fungi but excluding viruses, involving aerobic and anaerobic culture and the use of different culture media and including pathogen identification and antibiotic sensitivity testing, including any services specified in item 2084, 2088 and 2090-one or more sites. OP 37.15 2117 Cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 2083, to a maximum of three specimens in any seven day period-each examination. SP 60.00 2118 Cultural examination (including the detection of antigens not elsewhere specified in the Schedule) of faeces to determine the presence or absence of faecal pathogens, involving the use of at least two selective or enrichment media as well as culture in at least two different atmospheres and includes pathogen identification and antibiotic sensitivity testing, including any services specified in item 2084, to a maximum of three specimens in any seven day period-each examination. OP 45.00 2119 Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 2083. SP 84.00 2120 Microscopy with appropriate stains and cultural examinations of three specimens of sputum, urine or other bodily fluids for mycobacteria and any other bacterial pathogens, including pathogen identification and antibiotic sensitivity testing and including any services specified in item 2084. OP 63.00 2123 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing-each set of cultures to a maximum of three sets. SP 22.00 2124 Blood culture to determine the presence or absence of pathogenic micro-organisms excluding viruses, including serial cultures and sub-cultures, any relevant cultural methods and any tests necessary to identify any cultured pathogen and necessary antibiotic sensitivity testing-each set of cultures to a maximum of three sets. OP 16.50 2127 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). SP 26.50 2128 Urine examination including serial examination, with cell count, relevant stained preparations, culture, colony count by any method, identification of any cultured pathogens, antibiotic sensitivity testing when necessary, and with any relevant general examination for pH, specific gravity, blood, albumin, urobilinogen, sugar, acetone or bile salts. (Simple culture by dip slide is excluded from this item). OP 19.90 2129 Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella Zoster-one or more estimations. SP 21.00 2130 Direct detection of the antigens of Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus (in CSF and urine specimens only), RSV, cryptococcal antigens and Varicella Zoster-one or more estimations. OP 15.75 2133 Direct detection of Chlamydia from clinical material, not cultures-one or more estimations. SP 12.60 2134 Direct detection of Chlamydia from clinical material, not cultures-one or more estimations. OP 9.45 2135 Direct detection of Herpes simplex from clinical material, not cultures-one or more estimations. SP 12.60 2136 Direct detection of Herpes simplex from clinical material, not cultures-one or more estimations. OP 9.45 2139 Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 2133 and 2135. SP 36.50 2140 Investigation for Herpes simplex virus (one or more types) or Chlamydia trachomatis, in material obtained directly from a patient, by one or more cultural methods, including any services specified in items 2134 and 2136. OP 27.40 2145 Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy-one or more assays. SP 17.80 2146 Serology including IgG and IgM estimations of Rubella, toxoplasma or CMV when performed during pregnancy-one or more assays. OP 13.35 2181 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule-estimation of one antibody. SP 17.80 2182 Antibodies to microbial or exogenous antigens not elsewhere specified in the Schedule-estimation of one antibody. OP 13.35 2183 Two estimations specified in item 2181. SP 27.50 2184 Two estimations specified in item 2182. OP 20.65 2185 Three estimations specified in item 2181. SP 36.50 2186 Three estimations specified in item 2182. OP 27.40 2187 Four estimations specified in item 2181. SP 46.00 2188 Four estimations specified in item 2182. OP 34.50 2189 Five estimations specified in item 2181. SP 56.00 2190 Five estimations specified in item 2182. OP 42.00 2191 Six or more estimations specified in item 2181. SP 65.00 2192 Six or more estimations specified in item 2182. OP 48.75 2221 Hepatitis B surface antigen test. SP 17.80 2222 Hepatitis B surface antigen test. OP 13.35 2223 Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 2221, 2229 and 2231. SP 24.00 2224 Hepatitis B serology to define the immune status of an individual, including at least Hepatitis B surface antibody or Hepatitis B core antibody tests, including services specified in items 2222, 2230 and 2232. OP 18.00 2229 All serological tests performed for the identification of the agent causing acute hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core IgM antibody and Hepatitis A IgM antibody tests and those services specified in items 2221, 2223 and 2232. SP 47.50 2230 All serological tests performed for the identification of the agent causing acute hepatitis, which must include Hepatitis B surface antigen, Hepatitis B core IgM antibody and Hepatitis A IgM antibody tests and those services specified in items 2222, 2224 and 2232. OP 35.65 2231 All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 2221 and 2223. SP 34.50 2232 All tests performed in the follow up of a patient with proven Hepatitis B, including Hepatitis B surface antigen and either Hepatitis Be antigen or Hepatitis B surface antibody tests, including services specified in items 2222 and 2224. OP 25.90 2235 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent-one or more estimations. SP 31.50 2236 Antibiotics or anti-microbial chemo-therapeutic agents, concentration in serum, urine or other body fluid, by direct quantitative measurement of the agent-one or more estimations. OP 23.65 Division 4-Immunology 2239 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresisor immunofixation-one or more procedures. SP 39.00 2240 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246), on serum, urine or other body fluid, or examination of CSF for oligoclonal proteins by immunoelectrophoresisor immunofixation-one or more procedures. OP 29.25 2241 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1734, 1736 or 2245), on serum and urine concurrently collected-two or more procedures. SP 58.00 2242 Examination for, and identification of, a paraprotein (not previously identified), the presence of which is suggested by other tests (eg item 1735, 1737 or 2246), on serum and urine concurrently collected-two or more procedures. OP 43.50 2245 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method-estimation of one immunoglobin. SP 19.00 2246 Immunoglobulins G, A, M or D, quantitative estimation in serum, urine or other body fluid, by any method-estimation of one immunoglobin. OP 14.25 2251 Two estimations specified in item 2245. SP 29.50 2252 Two estimations specified in item 2246. OP 22.15 2253 Three or more estimations specified in item 2245. SP 40.00 2254 Three or more estimations specified in item 2246. OP 30.00 2255 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA-one or more estimations. SP 58.00 2256 Subclasses of Immunoglobulin G, 1 to 4, estimation where there is a reduced level of clinical significance of either total IgG or IgA-one or more estimations. OP 43.50 2257 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. SP 33.50 2258 Immunoglobulin E (total), quantitative estimation by any method or methods, with a maximum of two estimations in any twelve month period. OP 25.19 2259 Specific IgG or IgE antibodies to potential allergens-one or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period. SP 30.50 2260 Specific IgG or IgE antibodies to potential allergens-one or more tests for single or multiple allergens with a maximum of four estimations in any twelve month period. OP 22.90 2261 Antinuclear antibodies, detection in serum or other body fluids. SP 31.50 2262 Antinuclear antibodies, detection in serum or other body fluids. OP 23.65 2263 Quantitation of antinuclear antibodies and measurement of DNA binding (by Farr assay), performed only where a positive titre greater than 1 in 10 is obtained including services specified in item 2261. SP 70.00 2266 Quantitation of antinuclear antibodies and measurement of DNA binding (by Farr assay), performed only where a positive titre greater than 1 in 10 is obtained including services specified in item 2262. OP 52.50 2267 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids. SP 26.50 2268 Antibodies to extractable nuclear antigens, detection of in serum or other body fluids. OP 19.90 2269 Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2267. SP 42.00 2270 Characterization of antibodies to extractable nuclear antigens, performed only where a positive result is obtained including services specified in item 2268. OP 31.50 2271 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule-estimation of one antibody. SP 31.50 2274 Antibodies to tissue antigens which are not elsewhere specified in an item in the Schedule-estimation of one antibody. OP 23.65 2275 Two estimations specified in item 2271. SP 36.50 2276 Two estimations specified in item 2274. OP 27.40 2277 Three estimations specified in item 2271. SP 42.00 2278 Three estimations specified in item 2274. OP 31.50 2279 Four or more estimations specified in item 2271. SP 47.50 2280 Four or more estimations specified in item 2274. OP 35.65 2281 Rheumatoid factor, detection of by any technique. SP 12.60 2282 Rheumatoid factor, detection of by any technique. OP 9.45 2283 Quantitation of Rheumatoid factor where detected, including services specified in item 2281. SP 25.00 2284 Quantitation of Rheumatoid factor where detected, including services specified in item 2282. OP 18.75 2289 Complement-total and components-one quantitative estimation. SP 21.00 2290 Complement-total and components-one quantitative estimation. OP 15.75 2291 Two estimations as specified in item 2289. SP 31.50 2292 Two estimations as specified in item 2290. OP 23.65 2293 Three or more estimations as specified in item 2289. SP 42.00 2312 Three or more estimations as specified in item 2290. OP 31.50 2313 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. SP 39.00 2314 Leucocyte fractionation as a preliminary to leucocyte marker or leucocyte function tests. OP 29.25 2315 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). SP 66.00 2316 Functional tests for leucocytes, including use of all appropriate techniques (except E. rosette technique or similar and any test specified in the HAEMATOLOGY DIVISION of the Schedule). OP 49.50 2317 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 2319-one or more estimations. SP 84.00 2318 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques to assess lymphoid populations using a minimum of three monoclonal antibodies, including any services in item 2320-one or more estimations. OP 63.00 2319 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using, a minimum of seven monoclonal antibodies, including any services in item 2317-one or more estimations. SP 200.00 2320 Leucocyte surface marker characterization by immunofluorescence or immunoenzyme techniques in the investigation of a probable haematological malignancy using, a minimum of seven monoclonal antibodies, including any services in item 2318-one or more estimations. OP 150.00 2321 HLA typing comprising A, B, C and DR phenotypes. SP 89.00 2322 HLA typing comprising A, B, C and DR phenotypes. OP 66.75 2323 HLA typing, excluding any services specified in item 2321-one or more antigens. SP 36.50 2324 HLA typing, excluding any services specified in item 2322-one or more antigens. OP 27.40 2325 Mantoux test. SP 12.60 2326 Mantoux test. OP 9.45 Division 5-Histopathology 2327 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. SP 89.00 2328 Histopathology examination of biopsy material including all tissue processing, staining and professional opinion or opinions. OP 66.75 2329 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. SP 166.00 2330 Immediate frozen section diagnosis of biopsy material, including any other histopathology examination. OP 124.50 2331 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. SP 126.00 2332 Immunohistochemical investigation of biopsy material by one or more of immunofluorescent, immunoperoxidase or other labelled antibody techniques including any other histopathology examination. OP 94.50 2333 Electron microscopy of biopsy material including any other histopathology examination. SP. 134.00 2337 Electron microscopy of biopsy material including any other histopathology examination. OP. 100.50 Division 6-Cytopathology 2338 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes-one or more examinations. SP 19.40 2339 Cytological examination of smears from cervix or vagina for detection of pre-cancerous or cancerous changes-one or more examinations. OP 14.55 2340 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes-one or more examinations. SP 19.40 2341 Cytological examination including serial examinations of smears from skin, nipple discharge, lip, mouth, nose or anus for detection of pre-cancerous or cancerous changes-one or more examinations. OP 14.55 2343 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine, washings or brushings not specified in item 2340 and any histopathological service performed-one or more examinations. SP 38.00 2344 Cytological examination including serial examinations for malignant cells of body fluids, sputum (single specimen), urine, washings or brushings not specified in item 2341 and any histopathological service performed-one or more examinations. OP 28.50 2348 Cytological examination including examination of a series of three sputum or urine specimens for malignant cells. SP 79.00 2349 Cytological examination including examination of a series of three sputum or urine specimens for malignant cells. OP 59.25 2350 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. SP 47.50 2351 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues. OP 35.65 2355 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. SP 89.00 2356 Cytological examination of material obtained from a patient by fine needle aspiration of solid tissue or tissues where the aspiration is performed by a recognised pathologist, or where a recognised pathologist attends the aspiration and performs cytological examination during the attendance. OP 66.75 Division 7-Cytogenetics 2360 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood-one or more estimations. SP 172.00 2361 Chromosome studies, including preparation, count and karyotyping of one or more of amniotic fluid, bone marrow, skin and any other tissue or fluid excluding blood-one or more estimations. OP 129.00 2363 Chromosome studies, including preparation, count and karyotyping of blood. SP 156.00 2364 Chromosome studies, including preparation, count and karyotyping of blood. OP 117.00 2365 Chromosome indentification by banding techniques (using fluorescein, Giemsa, or centromere staining of high resolution analysis); or by fragile X-site determination-one or more identifications. SP 134.00 2366 Chromosome indentification by banding techniques (using fluorescein, Giemsa, or centromere staining of high resolution analysis); or by fragile X-site determination-one or more identifications. OP 100.50 Division 8-Infertility and pregnancy tests 2370 Semen examination for presence of spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). SP 8.80 2371 Semen examination for presence for spermatozoa or examination of cervical mucus for spermatozoa (Huhner's test). OP 6.60 2372 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period. SP 36.50 2373 Semen examination, involving measurement of volume, sperm count, motility, examination of stained preparations, morphology, and, if performed, differential count and one or more chemical tests, with a maximum of four examinations in any twelve month period. OP 27.40 2377 Sperm antibodies, sperm penetrating ability-one or more tests. SP 23.50 2378 Sperm antibodies, sperm penetrating ability-one or more tests. OP 17.65 2379 Chorionic gonadotrophin (beta-HCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy-one or more estimations. SP 12.80 2380 Chorionic gonadotrophin (beta-HCG), qualitative estimation in serum or urine by one or more methods, including serial dilution if performed, for diagnosis of pregnancy-one or more estimations. OP 9.60 2384 Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG-secreting neoplasm, threatened abortion or follow-up of abortion. SP 36.50 2385 Chorionic gonadotrophin (beta-HCG), qualitative (if performed) and quantitative estimation in serum by one or more methods for diagnosis of hydatidiform mole, HCG-secreting neoplasm, threatened abortion or follow-up of abortion. OP 27.40 Division 9-Simple basic pathology tests 2389 Blood count consisting of leucocyte count, erythrocyte sedimentation rate, examination of blood film (including differential leucocyte count) or any or all of haemoglobin estimation, haematocrit estimation or erythrocyte count-one procedure. 3.90 2390 Two procedures specified in item 2389 5.85 2391 Three or more procedures specified in item 2389 7.80 2393 Microscopical examination of urine. 3.90 2394 Pregnancy test by one or more immunochemical methods. 9.60 2395 Microscopical examination of wet film other than urine. 5.85 1396 Microscopical examination of gram stained film. 7.40 1397 Chemical tests for occult blood in faeces by reagent stick, strip, tablet or similar method. 1.95 2398 Microscopical examination screening for fungi in skin, hair or nails-one or more sites. 5.85 2399 Mantoux test. 9.60 2400 Seminal examination for presence of spermatozoa. 5.85 ------------------------------------------------------------------------------ -- LISTS OF ABBREVIATIONS A. ABBREVIATIONS FOR GROUPS OF TESTS ------------------------------------------------------------------------------ -- Group Estimations Included in Group Abbreviation Item Numbers ------------------------------------------------------------------------------ -- Cardiac Enzymes Lactate dehydrogenase LD, Aspartate Aminotransferase (AST) and Creatine kinase (CK). CE 1562, 1563 Coagulation Studies Prothrombin time, activated partial thromboplastin time and fibrinogen plus one or more of the following tests-Bleeding time, thrombin clotting time, fibrinogen degradation products, fibrin monomer, D-dimer, Factor XIII screening tests COAG 1527, 1528 Electrolytes Sodium (NA), Potassium (K), Chloride (CL) and Bicarbonate (HCO3). E 1564, 1565 Lipid Studies Cholesterol (CHOL) and Triglycerides (TRIG), FATS 1560, 1561 Liver Function Tests Alkaline phosphatase (ALP), Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Albumin (ALB), Bilirubin (BIL), Gamma glutamyl transpeptidase (GGT), Lactate dehydrogenase (LDH) and Protein (PROT). LFT 1571, 1572 Syphilis Serology Rapid plasma reagin test (RPR) or venereal disease research laboratory test (VDRL) and Treponema pallidum haemagglutin test (TPHA) or Fluorescent Treponemal antibody-absorpotion test (FTA) STS 2183, 2184 ------------------------------------------------------------------------------ -- B. ABBREVIATIONS FOR INDIVIDUAL TESTS The abbreviations are listed alphabetically within Divisions. The Divisions are: HAEMATOLOGY CHEMICAL PATHOLOGY MICROBIOLOGY IMMUNOLOGY HISTOPATHOLOGY CYTOPATHOLOGY CYTOGENETICS INFERTILITY & PREGNANCY TESTS ------------------------------------------------------------------------------ -- Approved Item Name of test in Schedule Abbreviation Numbers ------------------------------------------------------------------------------ -- DIVISION 1 HAEMATOLOGY Antithrombin III ATH 1531, 1532 Abnormal haemoglobins-spectroscopic examination of blood AH 1419, 1420 Bleeding Time BT 1521, 1522 Blood coagulation factors-quantitative assays: Von Willebrands factor antigen VWA 1541, 1542 Von Willebrands factor VWF 1541, 1542 Fletcher Factor FF 1541, 1542 Fitzgerald Factor FGF 1541, 1542 Passovy Factor PF 1541, 1542 Factor II FII 1541, 1542 Factor V FV 1541, 1542 Factor VII FVII 1541, 1542 Factor VIII VIII 1541, 1542 Factor IX FIX 1541, 1542 Factor X FX 1541, 1542 Factor XI FXI 1541, 1542 Factor XII FXII 1541, 1542 Factor XIII FXIII 1541, 1542 Blood Film BF 1170, 1171 Blood Group Antibodies BGA 1417, 1418 Blood Grouping-ABO and RH (D antigen) BG 1187, 1188 Blood Group and blood group antibodies (group and hold) BGAB 1196, 1197 Blood Group Systems (Duffy, Kell, M&N factors, Rh phenotypes) BGS 1192, 1193 Bone Marrow Examination-Threphine BMET 1181, 1182 Bone Marrow Examination-Aspirate BMEA 1183, 1184 Coagulation Time CT 1521, 1522 Cold Agglutinins CAG 1419, 1420 Compatibility testing XMAT 1198, 1199 C-reactive protein CRP 1163, 1164 Differential Cell Count DIFF 1170, 1171 Direct Coombs test CMBS 1419, 1420 D-dimer test DD 1521, 1522 Erythrocyte Count RCC 1163, 1164 Erythrocyte Metabolic Enzymes ERYM 1176, 1177 Erythrocyte Sedimentation Rate ESR 1163, 1164 Erythrocyte Haemolysis ERYH 1176, 1177 Euglobulin clot lysis time ECLT 1531, 1532 Fibrinogen Degradation Products FDP 1521, 1522 Fibrin Monomer FM 1521, 1522 Fibrinogen FIB 1521, 1522 Full Blood Examination FBE 1172, 1173 Haemoglobin Estimation HB 1163, 1164 Haemoglobinopathy tests HMGP 1179, 1180 Heparin Cofactor II HRNC 1531, 1532 Heparin estimation HEPR 1539, 1540 Heterophile Antibodies (Infectious Mononucleosis Test) IM 1419, 1420 Leucocyte Count WCC 1163, 1164 Lupus Anticoagulant LUPA 1531, 1532 Metalbumin detection (Schumm's test) SCHM 1419, 1420 Plasminogen PLAS 1531, 1532 Partial Thromboplastin Time PTT 1521, 1522 Platelet Aggregation PLTG 1535, 1538 Platelet Count PLTC 1163, 1164 Protein C PROC 1531, 1532 Protein S PROS 1531, 1532 Prothrombin Time PT 1521, 1522 Red Cell Porphyrins-qualitative test RCP 1419, 1420 Reticulocyte Count RETC 1163, 1164 Test for Factor XIII deficiency F13D 1521, 1522 Thalassaemia Studies TS 1179, 1180 Thrombin Time TT 1521, 1522 Viscosity of blood or plasma VISC 1163, 1164 DIVISION 2 CHEMICAL PATHOLOGY Alanine Aminotransferase ALT 1558, 1559 Albumin ALB 1558, 1559 Alcohol (Ethanol) ETOH 1791, 1792 Alkaline Phosphatase ALP 1558, 1559 Alkaline Phosphatase Isoenzymes ALPI 1734, 1735 Amniotic Fluid Examination AFE 1726, 1727 Ammonia NH3 1791, 1792 Amylase AMS 1558, 1559 Angiotensin coverting enzyme ACE 1791, 1792 Aspartate Aminotransferase AST 1558, 1559 Bicarbonate HC03 1558, 1559 Bilirubin (all fractions) BILI 1558, 1559 Bilirubin (Neonatal) BILN 1791, 1792 Blood Gases GAS 1590, 1591 Calcium (total, dialysed or ionized) CA 1558, 1559 Calculus Analysis CALC 1595, 1596 Catecholamines CAT 1959, 1960 Cholinesterase CHSE 1791, 1792 Chloride CL 1558, 1559 Cholesterol CHOL 1558, 1559 Cystine (cysteine) CYST 1791, 1792 C-reactive protein CRP 1558, 1559 Creatine Kinase CK 1558, 1559 Creatine Kinase Isoenzymes CKI 1558, 1559 Creatine Kinase Isoenzymes-quantitative or qualitative estimation by Electrophoresis CKIE 1734, 1735 Creatinine C 1558, 1559 Cryoglobulins CGLB 1575, 1576 Cryofibrinogen CFIB 1575, 1576 Dexamethazone Suppression test DEXA 2021, 2024 Drug or Chemical Assays-Overdose DRGO 1598, 1599 Drug Assays-Drug abuse treatment programme including urinary drug screen DRGA 1627, 1628 Drug Assays-Therapeutic: Antibiotics or antimicrobial chemotherapeutic agents (see under microbiology) Acetylated Sulphadimidine ASUL 1712, 1713 Amiodarone AMIO 1712, 1713 Amitriptyline AMIT 1712, 1713 Amylobarb AMYL 1712, 1713 Barbitone BARB 1712, 1713 Bromide BRMD 1712, 1713 Butobarb BUTO 1712, 1713 Carbamazepine (Tegretol) CARB 1712, 1713 Chloral Hydrate CHHY 1712, 1713 Chlorazepate CHZP 1712, 1713 Chlorpromazine CHLO 1712, 1713 Chloroquine CLOQ 1712, 1713 Cimetidine CMTD 1712, 1713 Clobazam CLOB 1712, 1713 Clonazepam (rivotril) CLON 1712, 1713 Cyclosporin A CLSA 1712, 1713 Desethyl Amiodarone DEAM 1712, 1713 Desipramine DESI 1712, 1713 Diazepam DIAZ 1712, 1713 Digoxin DIG 1712, 1713 Diphenylhydantion (Dilantin) DIL 1712, 1713 Disopyramide (Rythmodan) DISO 1712, 1713 Dothiepin DOTH 1712, 1713 Doxepin DOXE 1712, 1713 Ethosuximide (Zarontin) ETHO 1712, 1713 Flecainide FLEC 1712, 1713 Hydroxychloriquine HOCQ 1712, 1713 Imipramine IMIP 1712, 1713 Lignocaine LIGN 1712, 1713 Lithium LI 1712, 1713 Methadone MTDN 1712, 1713 Methotrexate MTTA 1712, 1713 Methsuximide MSUX 1712, 1713 Metronidazole MRDZ 1712, 1713 Mexilitine (Mexitil) MEX 1712, 1713 N Acetyl Procainamide NAPC 1712, 1713 N Desalkyl Clobazam NDAC 1712, 1713 N Desalkyl Doxepin NDAD 1712, 1713 Nitrazepam NITR 1712, 1713 Nordothiepin NDIP 1712, 1713 Nortriptyline NORT 1712, 1713 Oxazepam OXAZ 1712, 1713 Paracetamol PARA 1712, 1713 Paraquat PARQ 1712, 1713 Pentabarb PENT 1712, 1713 Phenobarbitone PHBA 1712, 1713 Phensoximide PHEN 1712, 1713 Primidone PRIM 1712, 1713 Procainamide PCAM 1712, 1713 Prominal PROM 1712, 1713 Propranolol PPNO 1712, 1713 Quinalbarb QUIB 1712, 1713 Quinine QNN 1712, 1713 Quinidine QUIN 1712, 1713 Salicylate-Asprin SALI 1712, 1713 Sotalol SALL 1712, 1713 Stellazine STEL 1712, 1713 Sulphadimidine SPDD 1712, 1713 Sulthiame (Ospolot) SUL 1712, 1713 Theophylline THEO 1712, 1713 Thiopentone TOPO 1712, 1713 Thioridazine THIO 1712, 1713 Tocainide TOCN 1712, 1713 Trimipramine TRIM 1712, 1713 Valproate (Epilum) VALP 1712, 1713 Warfarin WFR 1712, 1713 Therapeutic drugs which are not listed above must be written in full Electrophoresis EPP 1734, 1735 Elements: Aluminium AL 1871, 1872 Arsenic AS 1871, 1872 Beryllium BE 1871, 1872 Cadmium CD 1871, 1872 Chromium CR 1871, 1872 Copper CU 1871, 1872 Gold AU 1871, 1872 Lead PB 1871, 1872 Manganese MN 1871, 1872 Mercury HG 1871, 1872 Nickel NI 1871, 1872 Selenium SE 1871, 1872 Strontium SR 1871, 1872 Zinc ZN 1791, 1792 Enzyme assays of solid tissue or tissues ENZS 1969, 1970 Faecal Fat FFAT 1963, 1964 Faecal Haemoglobin (chemical test) FBT 1577, 1578 Faecal Porphyrins (qualitative test) FPR 1577, 1578 Faecal Reducing Substances FRS 1577, 1578 Faecal Haemoglobin (immunological test) FBI 1581, 1582 Fructosamine FRUC 1558, 1559 Gamma Glutamyl Transpeptidase GGT 1558, 1559 Globulin GLOB 1558, 1559 Glucose GLUC 1558, 1559 Glucose Tolerance Test GTT 1558, 1559 Glycosylated Haemoglobin (Hb Alc) GHB 2043, 2044 HDL Cholestrol HDLC 2039, 2040 Hormones: Adrenocorticotrophic hormone ACTH 2021, 2024 Aldosterone ALDS 2021, 2024 Androstenedione ANDR 2021, 2024 C-Peptide CPEP 2021, 2024 Calcitonin CALT 2021, 2024 Cortisol CORT 2021, 2024 Cyclic AMP CAMP 2021, 2024 Dehydroepiandrosterone sulphate DHEA 2021, 2024 Follicular Stimulating Hormone FSH 2021, 2024 Gastrin GAST 2021, 2024 Growth Hormone GH 2021, 2024 Hydroxyprogesterone OHP 2021, 2024 Insulin INS 2021, 2024 Luteinizing Hormone LH 2021, 2024 Oestradiol E2 2021, 2024 Oestriol E3 2021, 2024 Oestrone E1 2021, 2024 Parathyroid Hormone PTH 2021, 2024 Prolactin PROL 2021, 2024 Progesterone PROG 2021, 2024 Renin REN 2021, 2024 Sex Hormone Binding globulin SHBG 2021, 2024 Testosterone TES 2021, 2024 Urine Steroid Fraction or Fractions USF 2021, 2024 Vasoactive Intestinal Peptide VIP 2021, 2024 Hormone Receptor Assay HRA 2037-2038 HIAA (Hydroxyindoleacetic acid) HIAA 1791, 1792 HMMA (Hydroxy Methoxy Mandelic acid previously known as VMA) HMMA 1959, 1960 HVA (Homovanillic acid) HVA 1959, 1960 Hydroxproline HYDP 1791, 1792 Intestinal disaccharidases INTD 1969, 1970 Iron Studies (Iron, Transferrin and Ferritin) IS 1752, 1753 Lactate LACT 1791, 1792 Lactate Dehydrogenase LDH 1558, 1559 Lactate Dehydrogenase Isoenzymes LDI 1734, 1735 Lecithin/Sphingomyelin Ratio (Amniotic fluid) LS 1726, 1727 Lipase LIP 1558, 1559 Magnesium MG 1558, 1559 MHPG (Methoxy Hydroxy Phenyethylene Glycol) MHPG 1959, 1960 Osmolality, Serum or Urine OSML 1583, 1584 Oxalate OXAL 1791, 1792 PAA (Phenyl Acetic Acid) PAA 1959, 1960 Palmitic acid in amniotic fluid PALM 1726, 1727 pH measurement of body fluids other than urine PH 1575, 1576 Phosphate PHOS 1558, 1559 Porphyrins (quantitative test, one or more fractions) PR 1959, 1960 Potassium K 1558, 1559 Prostatic Acid Phosphatase (one or more fractions) ACP 1738, 1739 Protein (Total) PROT 1558, 1559 Protein-Quantitative Estim. of Specific Protein: Alpha feto protein AFP 1738, 1739 Alpha-1 antitrypsin AAT 1738, 1739 Alpha-2 microglobulin AMIC 1738, 1739 Beta-2 microglobulin BMIC 1738, 1739 CA-125 antigen C125 1738, 1739 CA-19.9 antigen CA19 1738, 1739 CA-15.3 antigen CA15 1738, 1739 C-1 esterase inhibitor CEI 1738, 1739 Caeruloplasmin CPLS 1738, 1739 Carcinoembryonic antigen CEA 1738, 1739 Ferritin FERR 1738, 1739 Haptoglobins HGLB 1738, 1739 Microalbumin MALB 1738, 1739 Prostate specific antigen PSA 1738, 1739 Transferrin TRAN 1738, 1739 Pyruvate PVTE 1791, 1792 Red Cell Folate and Serum B12 and if required, serum folate RCF 1770, 1771 Serum B12 B12 1768, 1769 Serum Folate FOL 1768, 1769 Sodium NA 1558, 1559 Synacthen Stimulation Test SYNS 2021, 2024 Thyroid Function Tests TFT 1983, 1984 Thyrotrophin Releasing Hormone Test TRH 1985, 1986 Triglycerides TRIG 1558, 1559 Urate URAT 1558, 1559 Urea U 1558, 1559 Urine Bilirubin UBIL 1575, 1576 Urine Cystine (Cysteine) UCYS 1575, 1576 Urine Haemoglobin UHB 1575, 1576 Urine Melanin (Melanogen) UML 1575, 1576 Urine Myoglobin UMY 1575, 1576 Urine Porphobilinogen UPG 1575, 1576 Urine Porphyrins (qualitative test) UPR 1575, 1576 Urine Urobilinogen UUB 1575, 1576 Vitamin Quantitative Estimation of Vitamins A, B1, B2, B3, B6, C or E VIT 1780, 1783 Vitamin D VITD 1786, 1787 Xylose XYL 1791, 1792 DIVISION 3-MICROBIOLOGY Antibiotic and antimicrobial chemotherapeutic agents, quantitative assay QAA 2235, 2236 Blood Culture BC 2123, 2124 Cultural Examination of Faeces FCS 2117, 2118 Herpes Simplex Virus Investigation by Cultural Methods HSVC 2139, 2140 Chlamydia Investigation by Cultural Methods CHLC 2139, 2140 Microbial Antibody Testing: IgG, IgM, IgA, or total antibodies may be tested against various organisms. These are indicated by placing the letter G, M A and T respectively on the end of the 3 letter abbreviation Actinomycetes ACT 2181, 2182 Adenovirus ADE 2181, 2182 Aspergillus ASP 2181, 2182 Avian Precipitins (Bird Fancier's Disease) APP 2181, 2182 Blastomyces BLM 2181, 2182 Bordetella pertussis BOR 2181, 2182 Borrelia Berghoffer BOB 2181, 2182 Brucella BRU 2181, 2182 Campylobacter Jejuni CAM 2181, 2182 Candida CAN 2181, 2182 Chlamydia CHL 2181, 2182 Coccidioides CCC 2181, 2182 Coxsackie B1-6 COX 2181, 2182 Cryptococcus CRY 2181, 2182 Cytomegalovirus CMV 2181, 2182 Cytomegalovirus serology in pregnancy CMVP 2145, 2146 Dengue DEN 2181, 2182 Diphtheria DIP 2181, 2182 Echinococcus ECC 2181, 2182 Echo-coxsackie group ECH 2181, 2182 Entamoeba Histolytica AMO 2181, 2182 Epstein Barr Virus EBV 2181, 2182 Fluorescent Treponemal antibody-absorption test (FTA-ABS) FTA 2181, 2182 Haemophilus HUS 2181, 2182 Hepatitis delta antibody-Anti-delta HDA 2181, 2182 Histoplasma HIP 2181, 2182 Hydatid HYD 2181, 2182 Influenza A FLA 2181, 2182 Influenza B FLB 2181, 2182 Legionella pneumophila-Serogroup 1 LP1 2181, 2182 Legionella pneumophila-Serogroup 2 LP2 2181, 2182 Leishmaniasis LE1 2181, 2182 Leptospira LEP 2181, 2182 Listeria LIS 2181, 2182 Measles MEA 2181, 2182 Micropolyspora faeni MIC 2181, 2182 Mumps MUM 2181, 2182 Murray Valley Encephalitis MVE 2181, 2182 Mycoplasma pneumoniae MYC 2181, 2182 Neisseria gonorrhoea GON 2181, 2182 Newcastle Disease NCD 2181, 2182 Parainfluenza 1 PF1 2181, 2182 Parainfluenza 2 PF2 2181, 2182 Parainfluenza 3 PF3 2181, 2182 Paratyphi PTY 2181, 2182 Pertussis PER 2181, 2182 Pneumococcus PCC 2181, 2182 Poliomyelitis PLO 2181, 2182 Proteus OX 19 POX 2181, 2182 Proteus OXK POK 2181, 2182 Q fever QFF 2181, 2182 Rapid Plasma Reagin test RPR 2181, 2182 Respiratory Syncytial Virus RSV 2181, 2182 Ross River Virus RRV 2181, 2182 Rubella RUB 2145, 2146 Rubella Serology in Pregnancy RUBP 2181, 2182 Salmonella typhi (H) SAH 2181, 2182 Salmonella typhi (O) SAO 2181, 2182 Schistosoma STO 2181, 2182 Streptococcal Serology-Anti-D-NASE B titre ADNB 2181, 2182 Streptococcal Serology-Anti-Streptolysin O ASOT 2181, 2182 Tetanus TET 2181, 2182 Thermoactinomyces vulgaris THE 2181, 2182 Thermopolyspora TPS 2181, 2181 Toxocara TOC 2181, 2182 Toxoplasma TOX 2181, 2182 Toxoplasma serology in pregnancy TOXP 2145, 2146 Treponema pallidum haemagglutin test TPHA 2181, 2182 Trichonosis TOS 2181, 2182 Typhus, Weil-Felix TYP 2181, 2182 Varicella zoster VCZ 2181, 2182 Venereal Disease Research Laboratory (VDRL) VDRL 2181, 2182 Yersinia enterocolytica YER 2181, 2182 Microbial antibody tests which are not listed above must be written in full Hepatitis Serology Hepatitis Serology in acute hepatitis HEP 2229, 2230 Hepatitis B Serology in follow-up of proven Hepatitis B HEPB 2231, 2232 Hepatitis B surface Antigen HBsAg HBSA 2221, 2222 Hepatitis B Serology to define immune status HEPI 2223, 2224 Microbial Antigen Testing: Chlamydia CHLY 2133, 2134 Herpes Simplex Virus HSV 2133, 2134 CSF antigens-Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, Group B streptococcus CSFA 2129, 2130 Cryptococcal antigen CRYN 2129, 2130 RSV-respiratory Syncytial virus RSVN 2129, 2130 Varicella zoster VCZN 2129, 2130 Microscopic examination of material other than blood M 2083, 2084 Microscopic examination of faeces for parasites OCP 2085, 2086 Microscopy and culture of material from Nose, Throat, Eye or Ear MCS1 2087, 2088 Microscopy and culture of material from Skin, Super-ficial sites, urethra, vagina, cervix, sputum or Rectum MCS2 2089, 2090 Microscopy and culture of material from post Operative Wounds, Aspirations of Body Cavities, Synovial fluid, CSF and operative or biopsy specimens MCS3 2098, 2099 Microscopy and culture of Sputum for Mycobacteria AFB 2119, 2020 Urine microscopy, culture, identification and sensitivity UMCS 2127, 2128 DIVISION 4-IMMUNOLOGY Specific IgG or IgE antibodies ALLG 2259, 2260 Antibodies to Tissue Antigens: Acetylcholine Receptor ARA 2271, 2274 Adrenal cell ADR 2271, 2274 Cardiolipin ACL 2271, 2274 Centromere ACA 2271, 2274 Gliad in IgA GLIA 2271, 2274 Gastric parietal cell PCA 2271, 2274 Glomerular basement membrane GBA 2271, 2274 Insulin Receptor Antibodies INSA 2271, 2274 Intercellular cement substance of skin ICCS 2271, 2274 Jo-1 JO1 2271, 2274 Keratin KERA 2271, 2274 Liver/Kidney microsomes LKA 2271, 2274 Mitochondria MA 2271, 2274 Parathyroid PTHA 2271, 2274 PM-1 PM1 2271, 2274 Reticulin RCA 2271, 2274 Rheumatoid Factor (all tests including Latex test) RF 2281, 2282 SCL 70 SCL 2271, 2274 Skeletal Muscle SLA 2271, 2274 Skin basement membrane SKA 2271, 2274 Smooth Muscle SMA 2271, 2274 Thyroglobulin TGA 2271, 2274 Thyroid Microsomal TMA 2271, 2274 TSH Receptor Antibody test TSHA 2271, 2274 Tissue antigens which are not listed above must be written in full Antibodies to Nuclear Antigens-detection ANA 2261, 2262 Antibodies to Nuclear Antigens-quantitation and measurement of DNA binding if positive ANA ANAP 2263, 2266 Antibodies to Extractable Nuclear Antigens-detection ENA 2267, 2268 Antibodies to Extractable Nuclear Antigens-characterization of antibodies if positive ENA ENAP 2269, 2270 Complement total, C3 or C4 COM 2289, 2290 Other complements must be specified HLA Typing, comprising A, B, C and DR phenotypes HLA 2321, 2322 HLA Typing, one or more antigens HLAN 2323, 2324 Immunoglobulins G, A, M or D IG 2245, 2246 Immunoglobulin G, sub classes 1-4 SIGG 2255, 2256 Immunoglobulins E IGE 2261, 2262 Leucocyte Fractionation LF 2313, 2314 Leucocyte functional Tests LFF 2315, 2316 Leucocyte Surface Markers to assess Lymphoid populations LSML 2317, 2318 Leucocyte Surface Markers in investigation of probable haematological malignancy LSMH 2319, 2320 Mantoux Test MANT 2325, 2326 Paraprotein Investigation by Immuno-electrophoresis or immunofixation PPRO 2239, 2240 Paraprotein Investigation on concurrently collected serum and urine PPSU 2241, 2242 DIVISION 5 HISTOPATHOLOGY Electron microscopy and biopsy material EM 2333, 2337 Histopathology of biopsy material HIST 2327, 2328 Immediate frozen section diagnosis of biopsy material FS 2329, 2330 Immunohistochemical investigation of biopsy material IHIS 2331, 2332 DIVISION 6 CYTOPATHOLOGY Cytology from cervix or vagina CXCY 2338, 2339 Cytology from skin, nipple discharge, lip, mouth, nose or anus SMCY 2340, 2341 Cytology from body fluids, urine or washing BFCY 2340, 2341 Cytology from body fluids, aspiration of solid tissues FNCY 2350, 2351 Cytology from fine needle aspiration of solid tissues-aspiration or attendance by pathologist FNCP 2355, 2356 DIVISION 7 CYTOGENETICS Chromosome studies CS 2360, 2361 Chromosome studies of blood CSB 2363, 2364 Chromosome identification by banding techniques CSI 2365, 2366 DIVISION 8 INFERTILITY AND PREGNANCY TESTS Semen examination for spermatozoa SES 2370, 2371 Huhner's test HT 2370, 2371 Semen examination SEE 2372, 2373 Sperm antibodies SAB 2377, 2378 Sperm penetrating ability SPA 2377, 2378 Chorionic gonadotrophin for pregnancy diagnosis HCG 2379, 2380 Chorionic gonadotrophin for diagnosis of specified conditions HCGD 2384, 2385